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The studies conferred in this thesis were performed to establish an appropriate PCR methodology 
to target sex-chromosome specific genes for prenatal fetal sex determination in pregnant cows. 
The first study determined the effect of frozen and fresh plasma on cell-free fetal DNA (cffDNA) 
extraction for PCR-based fetal sexing and compared different DNA extraction methods on 
downstream PCR for fetal sexing in cows by detecting sex-chromosome-specific gene products. 
We found that none of the DNA extracts obtained from frozen plasma samples of cows (120-150 
days pregnant) yielded any male fetus-specific PCR products, although all cows were carrying 
male fetii. In contrast, male fetus-specific amplicons were successfully amplified in 5/6 DNA 
extracts obtained by the phenol-chloroform method when fresh plasma samples were used. 
Although the smaller sample size was a limitation, we further found that DNA extraction 
methodologies compared in the present study (DNeasy Blood & Tissue Kit, QIAamp DSP Virus 
Kit, QIAamp DNA Blood Midi Kit, NucleoMag cfDNA Isolation Kit, MagMAX cfDNA Isolation 
Kit, KAPA Express Extract Kit, Salting-out protocol, and Phenol-chloroform method) appeared 
to show variability in their ability to isolate fetal DNA from freshly harvested maternal 
plasma/blood of pregnant cows.  
The second study determined the minimum concentrations of cffDNA that must be present per 
milliliter of maternal plasma for successful extraction and PCR. In addition, we also compared Y-
specific sequence PCR-based fetal sexing results in the cows divided into two gestational stages. 
We concluded that the spiked serum and cellular DNA from aborted male fetii could be 
successfully re-extracted (Blood & Tissue Kit) from maternal plasma at all dilution rates (0.5-
100%). Furthermore, the lowest concentration of spiked fetal DNA for successful extraction (from 
maternal plasma) followed by Y-specific PCR and bAML PCR was found to be >31.25 pg/ml and 
>2ng/ml, respectively. Besides, we also found that the proportion of cows with a positive Y-
specific PCR outcome were higher (P<0.05) in 151-240 days pregnant cows (90%; CI: 55.5-99.75) 
than 60-150 days pregnant cows (33%; CI: 7.5-70.1). Lastly, we found that the lower limit (35 
pg/ml) of spiked male fetal DNA could be successfully recovered from maternal plasma of 
advanced pregnant cows (using Blood & Tissue Kit, DSP Virus Kit, and NucleoMag cfDNA 
Isolation Kit) for Y-specific PCR. However, there was variability in the Y-specific PCR results 
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when neat plasma samples from the same pregnant cows were processed for DNA extraction using 
these kits. 
In conclusion, fresh but not frozen plasma could be used for PCR-based prenatal fetal sexing. 
Moreover, due to variability between different DNA extraction methodologies, the PCR assay for 
fetal sex determination was unreliable for fetal sexing in pregnant cows. Besides, cffDNA could 
be consistently extracted from maternal plasma for Y-specific PCR when present at amounts 
≥31.25 pg/ml. Although a significantly higher proportion of samples from advanced pregnant cows 
yielded Y-specific fetal DNA amplicons, the study needs to be replicated on a large dataset to 
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1. GENERAL INTRODUCTION AND LITERATURE REVIEW 
1.1.  Beef industry: current status in Canada 
Based on the 2020-29 agricultural outlook by the Organization for Economic Co-operation and 
Development (OECD) and Food and Agriculture Organization (FAO), global meat production is 
expected to reach 366 million tonnes (carcass weight) by 2029. Compared to 2020, the herds from 
developed and developing countries are expected to account for approximately 19% and 81% of 
additional meat produced, respectively. Amongst the developed countries, Canada and the US are 
projected to produce 4% more meat in 2029 than in 2020 (OECD-FAO, 2020). As per the 2020 
industrial statistics of the Canadian Cattlemen’s Association (CCA), Canada has been producing 
nearly 1.55 million tonnes of beef every year, out of which 409,967 tonnes was exported in 2019, 
thereby making Canada one of the leading exporters of meat at a global level. These beef exports 
added 3.1 billion CAD$  to the country’s economy (CCA, 2020). Furthermore, the country’s beef 
industry has been the second-highest provider of farm cash receipts (as per the latest data from 
2015-19), thereby generating an 18 billion CAD$ annually for the Gross Domestic Product (GDP) 
(CCA, 2020). As per the 2021 data of CanFax Research Services (CRS), there are 3.53 million 
beef cows present in 59,784 ranches and farms (CRS, 2021a). According to the CCA, these 
ranches/farms harbor 84,740 operators who rely on beef production for more than 50% of their 
income (CCA, 2020). The CRS further reports that the western Canadian provinces of Alberta and 
Saskatchewan are home to more than half of the beef cattle, with approximately 1.5 and 1.1 million 
cattle, respectively (CRS, 2021a). The data from CCA suggests that the average number of beef 
cattle per farm in Alberta and Saskatchewan are 255 and 191, respectively, which is much higher 
than the national average of 169 (CCA, 2020). 
As per 2019 data of Beef Cattle Research Council (BCRC), 53,236 of 59,784 (89%) farms of 
Canada were involved in cow-calf operations. The commercial cow-calf producers mainly focus 
on raising steers for the feedlots, with some growing their own replacement heifers. Whereas, the 
seedstock breeders provide replacement bulls and heifers with better genetics for breeding 
purposes (BCRC, 2019a). 
According to the CRS, beef production in Canada increased by 25% from 2015-2019 due to herd 
expansion decisions based on more profitability (CRS, 2021b). Since 2016, the continuous positive 
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revenue that ranged from 97-287 CAD$/head has put the cow-calf sector in a really strong position 
(CRS, 2020). As per the 2020 industrial statistics of CCA, the calves have earned the most profit 
to the beef herds. Since the backgrounding and feedlot sectors are also dependent upon the cow-
calf operations for their functioning, the cow-calf sector is central to the success of the beef 
industry. In 2019, around 9.4 billion $(Canadian) have been generated in farm cash income by the 
beef cattle industry that is chiefly dependent on cow-calf operations (CCA, 2020). 
1.1.1. Cow-calf operations: status of reproductive management strategies in Canada 
The success and profitability of every cow-calf operation primarily rely on the birth of a calf/per 
cow each. Contracting the length of the breeding season is the predominant determinant of a shorter 
calving season which ultimately ensures uniformity in the calf crop, more pounds weaned, and 
enhanced reproductive performance of both heifers and cows. The western Canadian Cow-Calf 
Survey (WCCCS) of 2018 reported that only 20% of the western Canadian cow-calf producers 
have a breeding season of < 63 days (BCRC, 2019c). Furthermore, the Atlantic and central 
Canadian cow-calf producers have even more longer breeding and calving seasons than the 
western Canadian beef producers on average. However, adhering to the breeding season of 63 days 
could result in a more contracted calving season, with more economic benefits, decreased labor, 
time, and resources involved (BCRC, 2019c). As per the WCCCS (2018), March-May and 
February-April were the most common calving seasons for mature cows and heifers, respectively, 
in western Canada. However, the Ontario Cow-Calf Survey (OCCS) of 2018 reported the most 
common calving seasons for mature cows and heifers being March-June and March-May, 
respectively (BCRC, 2019b). In another study, northern Quebec and northern Ontario were 
observed to have concentrated calving in late May for mature cows, and heifers usually started 
calving a couple of weeks before cows (Lamothe, 2018). In western Canada and Ontario, an almost 
similar proportion of cows calved during the first 21 days of the calving season, with the respective 
figures being 55% and 54% (BCRC, 2019a).   
Producer decisions regarding the timing of calving during a year depend primarily on the 
marketability of calf crops. However, other essential factors such as the cost of feed, availability 
of grazing land, calf management and survivability, labor availability, and farming activities could 
influence calving seasons. Relatively higher demand for calves and more attractive prices during 
the fall had earlier influenced the cow-calf producers to choose late winter calving season (i.e., 
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early during the year) so that calves can attain more weight by the time of marketing. In contrast, 
some advocated the benefits of early spring calving during high pasture productivity, which 
provides lactating cows access to abundant, nutritious forage (Adams et al., 1994; Fontes et al., 
2020; Kruse et al., 2004; Lamb et al., 2016). Additionally, a defined breeding season facilitates 
planning for concentrating labor resources for their strategic use, especially in calving season (to 
observe cows for dystocia and post-partum reproductive problems), thereby controlling the non-
essential investments and decreasing the input costs in the production system. Moreover, spring 
calving also ensures better survivability of the newborn calves owing to favorable climatic 
conditions. This practice is the same as the other wild and domestic ruminants, who breed naturally 
and give birth to offspring in spring.  
Furthermore, when the breeding and calving seasons are confined to a defined window of time in 
a herd, the calves born in a particular time frame are more uniform in terms of their size and weight, 
which may fetch a relatively higher price in the market at the time of sale (Leupp et al., 2009; 
Rodgers et al., 2012). 
1.1.2. Cow-calf operations: fall pregnancy diagnosis 
Cattle pregnancy diagnosis is a crucial management tool for beef herds. It allows the producers to 
make informed decisions about winter feeding and marketing of animals depending on their 
pregnancy status. In a beef herd, the approximate cost of feeding a cow during 120 days of the 
winter period is US$ 220 (Prevatt, 2019), which constitutes one of the largest expenses of 
maintaining a cow in a beef cow herd. Therefore, pregnancy checking might allow producers to 
make decisions to potentially cull open cows so that they do not have to feed them throughout the 
winter or put them into a different feeding program leading to a different marketing strategy. 
Additionally, producers can also assess the reproductive performance of the breeding programs 
and determine if there is a need to identify potential factors/diseases for poor pregnancy rates in a 
year. Given these benefits and recommendations from veterinarians, the acceptance of pregnancy 
diagnosis as a routine farm practice appears to have gradually increased over the last four decades. 
Based on the producer surveys, about one-third of the Alberta beef herds in the late eighties used 
pregnancy checks, which grew to one-half in the late 90s (BCRC, 2019a). More recently, about 
two-thirds of the respondent herds in western Canada reportedly used pregnancy checks as one of 
the management practices as per WCCCS (2017) data (BCRC, 2019a). The remainder of the 
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producers who do not routinely check the pregnancy status of their cattle typically sell them in 
spring when the price for cattle is usually better than the previous fall. Based on the economic 
modelling (Muzzin & Ben-Ezra, 2015), pregnancy testing allows the producers to plan for the 
management of pregnant cows during the winter. The open cows can be culled or kept for 
overwintering to benefit from better spring prices next year, respectively. Such a decision should 
be based on the fall cull cattle prices, overwintering feed costs, and, more importantly, the expected 
average daily gain (ADG) during the winter. The ADG varies with the management system and 
dry lot feeding allows better ADG than swath or bale grazing (Muzzin & Ben-Ezra, 2015). Within 
the dry lot management systems, expected ADG of <1.2lb/day would favor a decision to cull the 
cattle in the fall at the time of pregnancy check (Muzzin & Ben-Ezra, 2015). 
Various methods of pregnancy diagnosis in cattle include rectal palpation, ultrasonography, and 
detection of pregnancy-associated glycoproteins (PAGs) in the blood of the cows (Fricke et al., 
2016; Northrop et al., 2019). As per 2019 data from BCRC, rectal palpation and ultrasonography 
are the most common methods used for pregnancy diagnosis in Canadian beef herds (BCRC, 
2019a). Earlier, 50% of the western Canadian beef producers checked their heifers and cows for 
pregnancy (Waldner et al., 2010). A similar figure (49%) was reported for the beef producers in 
Saskatchewan (Jelinski, 2012). According to WCCCS of 2017, approximately 62 and 17% of 
producers had their cows and heifers, respectively, checked for pregnancy status. Rectal palpation 
was the most commonly used method for pregnancy diagnosis; however, ultrasound is largely 
replacing rectal palpation for the vast majority of veterinarians and producers (BCRC, 2019a). 
Rectal palpation is a rapid and cost-effective method, and an experienced palpator can accurately 
diagnose pregnancy as early as 30-35 d. Real time brightness mode ultrasonographic exam could 
provide an accurate diagnosis as early as 25-28 d, however, it needs an experienced personnel, 
proper handling facility, and involves costly equipment (Hylan et al., 2009; Romano et al., 2006). 
Nevertheless, in western Canadian cow-calf herds, pregnancy diagnosis is usually carried out 
annually in the fall season, particularly from September to November, generally, 50-90 days after 
the end of the breeding season (Mortimer & Hansen, 2006; Waldner, 2005). The use of PAGs may 
be limited to remote areas where veterinarian visits are infrequent to justify taking blood samples 
from cows and submitted to a laboratory for pregnancy diagnosis. 
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1.1.3. Importance of fetal sexing at pregnancy diagnosis 
The objective for prenatal sex determination varies in sexually dimorphic species, from social 
issues or sex-related diseases in humans to management aspects in domesticated animals. 
Knowledge of the fetal gender before birth offers many potential benefits to purebred and 
commercial cow-calf operations. Knowing the fetal sex at the time of pregnancy diagnosis could 
be used to market pregnant cows carrying a fetus with specific gender to potential buyers. Cows 
carrying female fetii could be kept or sold for replacement heifer development programs within or 
outside herds. Cows carrying a male fetus would benefit purebred producers hoping to raise and 
sell future bull studs. Also, knowing the gender proportion of the future calf crop could help 
producers plan to sell steers for backgrounding or feedlot operations. Despite these advantages, 
prenatal fetal sexing has found limited use in beef herds compared to dairy cattle.  
1.1.4. Methods to determine the sex of future progeny 
Multiple tools have been developed for gamete (sperm), embryo, and fetus to select the future 
progeny of a particular sex that may be utilized for different breeding programs. For example, the 
producers that use artificial insemination (AI) may opt for frozen sex-sorted semen (primarily X-
bearing sperm) if they need additional replacement heifers in the next year. On the other hand, the 
use of sexed embryos would be suited for producers applying embryo transfer programs for genetic 
improvement of their herds. Beyond the embryonic stage, techniques for the prenatal sex 
determination of fetus would be appropriate for the producers engaged in natural breeding 
programs.  
Available methods for prenatal fetal sexing can be broadly categorized into genetic and non-
genetic or invasive and non-invasive procedures. Genetic methods would involve assessing and 
evaluating fetal chromosomal material obtained directly (Invasive: amniocentesis, chorionic villus 
sampling, fetal blood sampling, coelocentesis, and embryoscopy) or indirectly (Non-invasive: fetal 
DNA in maternal circulation). Non-genetic methods include the use of ultrasonography for fetal 
sex determination. The first documented use of these techniques in both humans and cattle has 
been presented in Table 1.1. 
The following subsections will discuss different techniques to determine the sex of the future 
progeny, their potential uses, and applications for the cattle industry. 
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Table 1.1: The first reported use of various prenatal diagnostic tools in humans and cattle. 















1983 (Brambati & Simoni, 
1983) 
2005 (Teksen et al., 2005) 
Fetal blood 
sampling 
1964 (Freda & Adamsons 
Jr, 1964) 
1974 (Comline et al., 1974) 
Coelocentesis 1993 (Jurkovic et al., 1993) Not used --- 
Embryoscopy 1954 (Westin, 1954) Not used --- 
Ultrasonography 1958 (Donald et al., 1958) 1987 (Hanzen & Delsaux, 
1987) 
Fetal DNA from 
maternal blood 
1997 (Dennis Lo et al., 
1997) 
1996 (Kadokawa et al., 
1996) 
1.1.4.1. Preconception selection by sperm sexing 
One of the rapid and easily adaptable means to select the sex ratio of calf-crop is by using sex-
sorted semen for AI. However, the requirements for a particular sex of progeny may vary for the 
dairy and beef cattle industry. Specifically, dairy farmers would opt for female calves to support 
the replacement heifer program whereas; beef producers would prefer male calves to have more 
steers available to enter the feedlots (Naniwa et al., 2019).  However, sex-sorted semen is more 
commonly used in the dairy industry due to the broader utilization of AI for breeding in dairy than 
beef cattle. As per the 2014 data of the WCCCS, AI was used by only 18% of the western Canadian 
beef producers (BCRC, 2018). 
The sperm-sexing technology was first utilized in rabbits (Johnson et al., 1989) and then later 
adapted to other species (De Graaf et al., 2014; Seidel Jr, 2012). Sexing of mammalian sperm on 
a commercial scale is based on the differences in the DNA content between X- and Y-
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chromosome-bearing sperm. Across different farm animal species, the X-chromosome-bearing 
sperm has 3.6% to 4.45% more DNA content than the Y-chromosome-bearing sperm (Seidel Jr, 
2012).  Cattle, in general, have 4% additional DNA in the X-sperm than Y-sperm; however, there 
are some variations between different breeds (Garner et al., 2013). The sperm sexing technology 
involved combining fluorescent staining (Hoechst 33342) of sperm with flow cytometry. The 
Hoechst 33342 is a cell-permeable stain that would bind to the minor groove of the DNA helix in 
the sperm (Garner, 2009). Upon excitation with laser, the differences in the intensity of stain would 
facilitate identifying X- and Y-sperm by the fluorescent detectors (Garner, 2009). Critical aspects 
of efficient sperm sorting include cell permeating dye, the flow of sperm in a single file in droplets, 
the orientation of sperm to the lasers and photodetectors while maintaining sperm viability 
throughout the process (Garner, 2009; Garner & Seidel, 2008). Studies have demonstrated that 
using sexed semen for in-vitro fertilization (Cran et al., 1993) and AI (Seidel et al., 1997) results 
in the birth of desired sex offsprings with a likelihood of nearly 90%. 
Since the initiation of SexedULTRATM technology, there has been a tremendous rise in the fertility 
of sexed semen (Vishwanath & Moreno, 2018). Therefore, the use of sexed semen has increased 
from 9.4% to 30.7% from 2007-2015 in the case of dairy heifers (Hutchison et al., 2016). While 
sexed semen has overtaken conventional semen in the case of Jersey cows, its use is increasing 
commonly in Holstein cows (Vishwanath & Moreno, 2018). By using SexedULTRATM semen, 
conception rates equalling 90% of the conventional semen have been observed (Vishwanath & 
Moreno, 2018). Presently, the fertility rates of both conventional and sexed semen have become 
almost equivalent (Heuer et al., 2017). Practically, the use of sexed semen in commercial cow-calf 
herds of Western Canada may be limited to the seedstock producers who use AI and embryo 
transfer programs for breeding (Hall & Glaze, 2014).  
1.1.4.2. Preimplantation embryo sexing 
Sex-ratio of the future progeny can also be selected by testing embryonic cells for Y-specific DNA 
probes (van Vliet et al., 1989), immunological assays of male-specific antigens such as H-Y 
antigen (Flores-Foxworth, 2007), cytogenetic analysis (Hirayama et al., 2013), and quantification 
of the X-linked enzymes (Vijaya Lakshmy et al., 2018). Immunological assay of H-Y antigen and 
quantification of X-linked enzymes are non-invasive but lack accuracy. In contrast, Y-specific 
DNA probes and cytogenetic analysis are highly accurate but require biopsy (Sharma et al., 2017). 
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With recent progress made in the field of molecular biology, relatively more quick and authentic 
techniques of embryo sexing such as fluorescent in-situ hybridization (FISH) using Y-specific 
DNA probes (Sharma et al., 2017) and polymerase chain reaction (PCR) (Vijaya Lakshmy et al., 
2018) have been introduced. 
Even though much progress has been made in bovine embryo sexing, relatively lower pregnancy 
rates following embryo transfer, along with the high costs of superstimulation, limits the use of 
this reproductive technique. Furthermore, like sperm sexing, this technique lacks practicality in 
commercial beef herds because of the non-intensive management of cows in pastures where they 
remain inaccessible during breeding. According to the data of Mississippi State University, 
embryo transfer was used by only 1.6% of the beef producers in the United States (Larson & 
Parish, 2015). 
1.1.4.3. Invasive methods of genetic fetal sexing 
Various diagnostic methods that involve breaching tissue layers allow visualization of fetus or 
acquisition of fetal cellular material were primarily developed for humans and later adapted for 
pregnant animals (Shulman et al., 2008). These procedures include amniocentesis, CVS, fetal 
blood sampling, coelocentesis, and embryoscopy/fetoscopy and have been briefly discussed 
individually in the subheadings below. 
1.1.4.3.1. Amniocentesis 
Amniocentesis refers to the extraction of amniotic fluid that surrounds the fetus in pregnant women 
and animals. The technique has been reportedly used since the late 1800s for aspirating excess 
amniotic fluid in the cases of women affected with hydramnios and was later adapted for 
amniography (Menees et al., 1930). The initial approach of transabdominal amniotic tap in women 
improved with the introduction of ultrasound in the 1970s. Currently, ultrasound-guided 
transabdominal amniocentesis is performed in humans from 16-week of pregnancy for early 
detection of chromosomal abnormalities, genetic disorders, and fetal maturity as well as diseases 
(Cruz-Lemini et al., 2014). 
The inactivated X-chromosome (Barr bodies) was discovered in the late 1940s (Barr & Bertram, 
1949). A decade later, amniotic cellular material was obtained from mid-pregnancy 
(vaginally/laparoscopically) that was used for fetal sex determination in pregnant women (Fuchs 
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& Riis, 1956). The Barr body represents inactivated condensed X-chromosome present in the 
nucleus, which could be detected using Cresyl violet staining in amniotic samples from women 
carrying a female fetus (Barr & Bertram, 1949). However, the accuracy of Barr bodies detection 
may be limited by the contamination with maternal cells in all species and similarities between 
prominent chromocenters (not linked to sex) observed in some mammals such as rodents (Nayyar 
& Barr, 1966). Alternatively, the amniotic cells can be cultured for karyotyping or processed for 
DNA isolation to assess the presence of sex-chromosome-specific genes using PCR. 
In cattle, amniocentesis has been carried out using needle insertion through vaginal fornix (Bongso 
& Basrur, 1975), sacrosciatic ligament (Bongso et al., 1978), ischiorectal approach (Eaglesome & 
Mitchell, 1977), flank surgery (Leibo & Rall, 1990) and transvaginal ultrasound (Garcia & 
Salaheddine, 1997). One of the first reports on amniocentesis in cattle described the vaginal 
approach on 70-100 d pregnant cows. It involved using a 12”, 18-gauge needle introduced into the 
dorsal fornix to aspirate amniotic fluid followed by in-vitro culture of fetal cells for cytogenetic 
evaluation (Bongso & Basrur, 1975). A subsequent study used right flank and/or vaginal 
approaches in six pregnant (4-8 months) dairy cows to determine the sex of the fetus that resulted 
in two abortions and one preterm birth (Inoue et al., 1982). In a later study, amniotic samples from 
>1000 pregnant (7-22 wk) cows in an embryo transfer program were collected using a left flank 
surgical approach under sedation and local anesthesia (Leibo & Rall, 1990). Following the 
collection, amniotic cells needed 10-13 d of in-vitro culture to reach concentrations sufficient for 
metaphase spread analyses. Amongst the 216 cows that continued the pregnancy, approximately 
13% abortion rate was observed. Compared to other approaches, ultrasound-guided transvaginal 
amniocentesis using fine needle (22-gauge) puncture was more efficient as the operator can 
visualize the needle path and is unlikely to cause abortions (Kamimura et al., 1997). Nevertheless, 
ultrasound-guided transvaginal amniocentesis would require caudal epidural anesthesia, well-
trained personnel, took on average 20 min/animal and might be associated with sample collection 
failure in some cows (Kamimura et al., 1997). Although amniocentesis is a great tool to obtain 
valuable fetal cells during pregnancy for prenatal diagnostic applications, the procedure poses a 
significant risk to the fetal viability in-utero, requires a high degree of skill and expertise, and 
additional turnaround time for the results of cytogenetics or PCR. 
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1.1.4.3.2. Chorionic villus sampling (CVS) 
Besides amniocentesis, CVS remains the commonly used technique for prenatal screening and 
diagnosing chromosomal and genetic disorders in humans (Carlson & Vora, 2017). As the name 
implies, CVS involves collecting fetal components of the placenta (chorionic villi). This technique 
was first used in pregnant women in the late 1960s using endoscopes through a transcervical 
approach (Mohr, 1968). Since the chorionic villi originate from the trophoblast layer of an embryo, 
the CVS can be used to determine fetal sex and the fetus's genetic makeup. Currently, the CVS is 
carried out in 10-13 wk of pregnancy in women through either transcervical or ultrasound-guided 
transabdominal approaches. Over the last six decades, the equipment and technique have evolved 
to minimize the risk of pregnancy losses due to bleeding, amniotic leakage, and limb reduction 
associated with CVS (Carlson & Vora, 2017). Instead of using biopsy forceps during the early 
years, specialized catheters or fine gauge needles are used to take the villus sample (Carlson & 
Vora, 2017). In a recent metanalysis, the pregnancy loss associated with the CVS sampling in twin 
pregnancy in women is similar to those observed in women that did not undergo CVS (Mascio et 
al., 2020). Despite continued use in humans, the CVS has not been adapted for cattle, likely due 
to the differences in the type of placentation. The chorionic villi in cattle interdigitate into the 
maternal crypts only at the specialized placentation sites (caruncles) in the uterus. Only available 
literature in cattle describes the collection of fluid using CVS from the placenta obtained after 
slaughter and microdissection of cotyledons to obtain cells for a short culture followed by 
karyotyping of mitotic cells (Teksen et al., 2005). Although not impossible, the collection of fluid 
by CVS would require an ultrasound-guided method (vaginally or transabdominal), sedation, or 
regional anesthesia and trained personnel. 
1.1.4.3.3. Fetal blood sampling 
Fetal blood sampling evolved from the initial work on using hysteroscopy (transcervical) or an 
endoscope (transabdominal) in an attempt to direct blood transfusion to the fetus affected with 
hemolytic diseases (Westin, 1954). Two decades later, the fetal blood sample was collected for the 
first time using a pediatric cystoscope to diagnose blood disorders (Valenti, 1973). In the early 
1980s, the technique of ultrasound-guided pure fetal blood sampling in-utero was developed that 
involved blood aspiration from the umbilical vein by inserting a fine needle at the base of the 
umbilical cord (Daffos et al., 1983, 1985). The new technique was called ultrasound-directed 
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percutaneous umbilical blood sampling (PUBS) and replaced the fetoscopy for cordocentesis 
(Shulman et al., 2008). Initially, the primary focus of fetal blood sampling was to prenatally assess 
fetal hematologic abnormalities (Ryan & Rodeck, 1993). The PUBS, an invasive technique, has 
been associated with blood loss, lowered fetal heart rate, and abortion and therefore is 
recommended mainly for the diagnosis and management of hematological disorders of the fetus in 
human medicine (Berry et al., 2013; Peddi et al., 2021).  
In veterinary medicine, fetal catheterization initially emerged as a tool providing access to fetal 
blood for in-vivo research on acid-base balance, oxygenation, and endocrinology of the fetii. 
Various surgical techniques for the introduction and subsequent maintenance of catheters in the 
uterine and umbilical blood vessels have been established for sheep and goats (Meschia et al., 
1965), cattle (Comline et al., 1974), mare (Comline et al., 1975), and pig (Randall, 1977). On the 
other hand, a few follow-up studies reported that the installation of catheters had a high failure rate 
in cattle (Aoki et al., 2002; Schmidt et al., 2004). The fetal blood sampling has a low potential for 
fetal sex determination in cattle due to the invasive nature of the procedure, risk of complications 
such as septicemia, peritonitis, and abortions, and the availability of non-invasive methods. 
1.1.4.3.4. Coelocentesis 
As the name indicates, coelocentesis involves aspiration (centesis) of fluid from the 
extraembryonic fluid-filled cavity (coelom) that forms between two mesodermal layers and 
surrounds the amnion and yolk sac. The coelom appears by the end of the fourth week of gestation 
in humans (Hamilton & Boyd, 1960; Jones & Jauniaux, 1995) and by the third week in cattle 
(Greenstein & Foley, 1958). In humans, coelocentesis is carried out between six and nine weeks 
(coelom is larger than amnion during this period) of pregnancy using transabdominal or 
transvaginal ultrasound-guided approaches as an early prenatal diagnostic tool for fetal diseases 
(Aiello et al., 2018; Hamilton & Boyd, 1960; Jauniaux et al., 2003). The cells harvested from 
coelocentesis could be used for chromosomal analysis, molecular diagnosis, and potentially sex 
determination (Jurkovic et al., 1993; Pietropolli et al., 2014). Quantitative PCR (Findlay et al., 
1996) and fluorescence in-situ hybridization (Pandya et al., 1995) following coelocentesis have 
proved to be helpful in fetal sex determination in humans (Jurkovic et al., 1993). The transvaginal 
coelocentesis in women has been associated with a higher risk of abortions (25%) (Ross et al., 
1997), whereas the transabdominal approach requires highly skilled operators (Pietropolli et al., 
12 
 
2014). Current literature does not provide evidence on coelocentesis in cattle to collect cells of 
fetal origin. 
1.1.4.3.5. Embryoscopy 
Embryoscopy refers to the procedure of visualization of embryo in-utero following the insertion 
of an endoscope into the extracoelomic cavity through either the transabdominal route or 
transcervical route (Cullen et al., 1990). This procedure is sometimes called embryofetoscopy and 
is used in pregnant women between five to 11 weeks of pregnancy to evaluate missed abortions, 
high-risk pregnancies, and fetal syndromes (Paschopoulos et al., 2006; Vicente et al., 2020). This 
technique can potentially be used for fetal sex determination in women >9 weeks pregnant; 
however, miscarriage has been reported in 12% of the women undergoing this procedure (Ville et 
al., 1997). Additionally, a routine transabdominal B-mode ultrasound examination would provide 
information about the fetal sex without risking the pregnancy in women, although at a later 
gestational age. In cattle, none of the available literature describes the use of embryoscopy for fetal 
sex determination. 
1.1.4.4. Ultrasonography 
Since the first report of two-dimensional ultrasound images of a human fetus in an abdominal scan 
in 1958 (Donald et al., 1958), the brightness mode real-time ultrasonography has improved image 
resolution substantially for use in both human and animal gynecology and obstetrics. About two 
decades later, Stocker and his colleagues recorded the fetal sex in pregnant women (third trimester) 
using ultrasound (Stocker & Evens, 1977). While visualizing the perineal region of the fetus in 
transverse or sagittal planes, the authors used the presence of external genitalia indicative of a 
male, while its absence indicated a female. These ultrasound observations were confirmed against 
the gender of the baby at birth. The observed accuracy in this study was 95% and 91.5% in the 
diagnoses of a male and female singleton fetus, respectively. A subsequent study on women (10-
20 weeks pregnant) described the differences in angulation of external genitalia of the male and 
female fetus when viewed in the sagittal plane for fetal sex determination (Emerson et al., 1989). 
The external genitalia of the male fetus (fetal phallus) is angled vertically or cranially, while that 
of a female fetus (representing clitoris) is characteristically angled caudally (Emerson et al., 1989). 
Later studies indicated that the accuracy of fetal sex determination during the first trimester in 
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women would vary with fetal age and sonographer skills (Colmant et al., 2013; Kearin et al., 2014; 
Manzanares et al., 2016). 
Transrectal ultrasonography can be considered a minimally invasive method to evaluate the bovine 
female genital tract (its contents) and ovaries. The initial study in cattle reported an accuracy of 
94% (42/54) to determine fetal sex between 73 to 120 days post-conception (Müller & Wittkowski, 
1986). The sex of the fetus was assessed by the presence of the external feature of mammary buds 
in a female or scrotal (genital) swelling in a male (Müller & Wittkowski, 1986). The researchers 
did not observe genital tubercle in the male or female fetus, likely due to the low resolution of the 
ultrasound machines available during that period. Subsequently, with the improved resolution of 
ultrasound machines, the bovine fetal sex determination at early stages in dairy cows was reported 
based on the location of echogenic bilobed genital tubercle in relation to other embryonic 
structures (Curran et al., 1989). The genital tubercle in an embryo represents the prime structure 
of mesodermal origin (Noden & Lahunta, 1985) and is present between the two fetal hindlimbs at 
day 48-49 of gestation (Curran et al., 1989). Based on daily transrectal ultrasound observations, 
the genital tubercle was observed to translocate cranially towards the umbilical cord in a male fetus 
and caudally towards the base of the tail in a female fetus (Curran et al., 1989). By day 55, the 
genital tubercle was located caudal to the umbilicus in the male fetus or cranial to the tail base in 
the female fetus (Curran et al., 1989), likely under the influence of sex hormones secreted by fetal 
gonads. The sex of fetii in this study was confirmed with the recovery of the aborted fetus at day 
60. Another study confirmed these observations and revealed 93% and 91% accuracy for male and 
female fetus detection, respectively, between days 56-80 (Kamimura et al., 1994). After day 70, 
the genital tubercle has reduced echogenicity due to the bilaterally present genital folds, which 
form prepuce and vulva in males and females, respectively (DesCoteaux et al., 2010). Field trials 
on a large dataset have reported accuracy of >98% for the fetal sex determination with an average 
time of 2 minutes per cow (Curran, 1992; Quintela et al., 2011). Consequently, fetal sexing using 
ultrasound has been adopted mainly by dairy herds. However, the technique has not been widely 
utilized by the beef cattle industry. Usually, a significant number of beef cattle, expectedly between 
3-5 months of gestation, are presented for the fall pregnancy checks, sometimes under limited 
handling facilities. Thus, there is less available time per cow for the ultrasound examination and a 
larger fetus along with reduced echogenic contrast between the embryonic structures reduce the 
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accuracy of fetal sex prediction. These factors contribute to a decreased likelihood of using 
ultrasound for prenatal sex determination in routine veterinary practice. 
1.1.4.5. Cell-free fetal DNA (cffDNA) in maternal peripheral blood 
The methods mentioned so far have several limitations for their broader use in the beef industry 
due to the level of skill and training required, invasiveness, and associated cost. As a result, there 
have been persistent efforts to identify novel strategies to aid in the sex-determination of future 
progeny. The discovery of cffDNA in the maternal circulation of pregnant women at the end of 
the 20th century provided a unique opportunity to perform non-invasive prenatal diagnosis (NIPD) 
(Dennis Lo et al., 1997). The NIPD is based on analyzing fetal DNA obtained by routine 
processing of a single peripheral blood sample drawn from a pregnant female without posing any 
risk to the developing fetus and mother (D’Aversa et al., 2018). The isolated fetal DNA can then 
be used to target sex-chromosome specific and other genetic markers (Dennis Lo et al., 1997; 
Devaney et al., 2011; Fernández-Martínez et al., 2012). Since the inception of this technique, 
cffDNA has been used for prenatal fetal sex determination in various mammals viz. cattle (Da 
Cruz et al., 2012; Lemos et al., 2011; Ristanic et al., 2018), sheep (Asadpour et al., 2015; Kadivar 
et al., 2013), mare (de Leon et al., 2012; Tonekaboni et al., 2020), elephant (Vincze et al., 2019), 
and rhinoceros (Stoops et al., 2018) with varying degree of accuracy. The more detailed 
information on cffDNA and its use in non-invasive genetic fetal sexing will be discussed in the 
upcoming section. 
1.2. Cell-free DNA (cfDNA) 
The presence of cfDNA was first documented when the circulating free nucleic acids were 
discovered in the plasma of clinically healthy and diseased individuals (Mandel, 1948). 
Subsequent research indicated that cfDNA commonly exists as short double-stranded 
deoxynucleic acid fragments (as low as 150 bp) and in low concentrations (on average <100 ng/ml) 
(Cicchillitti et al., 2017; Fleischhacker & Schmidt, 2007). Evidence suggests that the cfDNA is 
present predominantly in the cell-free fraction (plasma and serum) of the whole blood and other 
body fluids (Jahr et al., 2001; Stroun et al., 2000). 
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1.2.1. Source and clinical implications of cfDNA 
Even though the exact origins of cfDNA are debatable, the most likely sources of cfDNA include 
cell death (apoptosis, necrosis) and active release from cells (Grabuschnig et al., 2020). Cell death 
by apoptosis and necrosis would lead to cfDNA of different base pair lengths. Programmed cell 
death or apoptosis generally leads to cfDNA of ~150 bp or length in its multiple, similar to the size 
of a single or multiple nucleosomes (Stephanie et al., 2014). However, cfDNA smaller or 
intermediate base pair size can also be observed in various studies, possibly due to cleavage 
nucleases and technical differences in extraction or DNA library preparation (Ma et al., 2017). It 
is less likely that cfDNA would primarily originate from necrotic cell death, as necrosis in cancer 
patients was associated with larger DNA fragments (10Kbp) (Jahr et al., 2001). The various 
characteristics of cfDNA that support the apoptotic pathways being its key source include rapid 
turnover (Tsumita & Iwanaga, 1963) and short half-life of cfDNA in the circulation (Dennis Lo et 
al., 1999) through yet poorly understood mechanisms. 
Additional less studied processes that could potentially release cfDNA include phagocytosis, 
autophagy, and neutrophil extracellular trap formations (Brinkmann et al., 2004). Examples of the 
active release of cfDNA include mitochondrial DNA release through cell reparative changes (Mair 
et al., 2019) and extrachromosomal circular DNA through cellular excretory mechanisms (Anker 
et al., 1975; Zhu et al., 2017).  Lymphocytes and several other living cells of the body have been 
observed to spontaneously liberate some of their newly manufactured DNA (Stroun et al., 2001; 
Van Der Vaart & Pretorius, 2008). These observations indicate a possible role of cfDNA in 
performing the vital functions of the cells or its active participation in an intercellular signaling 
pathway to control the active intercommunication among the cells (Gardiner et al., 2015). 
While the source and function of the cfDNA may differ between physiological and pathological 
conditions, the predominant factor contributing to the release of cfDNA in circulation is 
pathological (Ranucci, 2019). The high concentrations of cfDNA have been reported in the 
plasma/serum of the patients with several disease conditions viz. trauma and myocardial infarction 
(Chang et al., 2003), stroke (Tsai et al., 2011), and various types of tumors, which suggest that 
cfDNA may be involved in a feedback association with inflammation and its liberation tends to 
initiate a proinflammatory cytokine response (Frank, 2016). Hence, a simple peripheral blood 
sample collection provides a practically feasible diagnostic option with an extensive scope of 
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clinical applications such as non-invasive early diagnosis to prognosis, foreseeing the response to 
anti-cancer therapy, and detecting minimal residual disease (Lewis et al., 2016; Ulrich & Paweletz, 
2017). Similarly, cffDNA that circulates in the blood of pregnant mammals also carries a great 
potential of being used as a prenatal diagnostic marker which is discussed in more detail in the 
upcoming section. 
1.2.2. Cell-free fetal DNA (cffDNA) 
The presence of intact fetal cells in the maternal blood has been debated since the first study 
indicated the presence of intact fetal cells (likely DNA) in the maternal blood of pregnant women 
using lymphocyte culture and karyotyping (Walknowska et al., 1969). A subsequent study reported 
fetal cells in blood samples obtained from pregnant women with flow cytometry (Herzenberg et 
al., 1979) and fluorescence in-situ hybridization (Poon et al., 2000). However, a later study could 
not confirm the findings of intact cells being present in maternal circulation (Bischoff et al., 2003). 
It has been estimated that each millilitre of maternal blood from pregnant women contains on 
average one fetal DNA equivalent (Bianchi, 1999; Sekizawa et al., 2000).  
The discovery of nucleic acids of fetal origin in the plasma of clinically healthy pregnant women 
by Dennis Lo and colleagues (Dennis Lo et al., 1997) provided the opportunity to develop a non-
invasive tool for prenatal screening and testing in human medicine. In a follow-up study, it was 
observed that the maternal plasma contains a higher proportion of maternal (94-97%) rather than 
fetal cfDNA (3-6%) (Dennis Lo, Tein, et al., 1998). A more recent study on prenatal testing of 
aneuploidy recorded a high variability (0.6-50%, mean 10.2%) in the cffDNA fraction in plasma 
of pregnant women (Curnow et al., 2014). The cffDNA in pregnant women was first detectable at 
4-5 weeks in gestation and was observed to undergo a rapid clearance following the delivery, 
suggesting that it is specific to pregnancy (Dennis Lo et al., 1999; Dennis Lo, Tein, et al., 1998). 
Further, the cffDNA in maternal plasma increased with the advancement of the gestational age of 
the fetus, whereas it decreased with increased body mass index and maternal age (Dar et al., 2016; 
Dennis Lo, Tein, et al., 1998). It has been estimated that the cffDNA content in maternal plasma 
increased at the rate of 0.1% per week between 9-20 weeks of gestation and then at 0.6% per week 
after 21 weeks of pregnancy in women (Dar et al., 2016). However, no such studies analyzing the 
relative proportion of fetal DNA compared to maternal DNA have been performed in domestic 
mammalian species to the best of our knowledge. 
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1.2.2.1. Source of cffDNA 
An older study provided evidence that cells from either side would cross over the placental 
interface in humans throughout the pregnancy (Desai et al., 1963). Initially, the cffDNA in the 
maternal blood was thought to be contributed by fetal nucleated erythrocytes and leukocytes 
(Bianchi, 1999; Walknowska et al., 1969), a hypothesis that was disproved by a later study (Angert 
et al., 2003). Another similar phenomenon responsible for the transfer of fetal cells to maternal 
circulation could be ‘microchimerism’ as it has been well documented that there is an occasional 
bi-directional exchange of cells between mother and the fetus during pregnancy in women 
(Shrivastava et al., 2019). Observations that cffDNA was higher in the amniotic fluid than maternal 
blood and was present in maternal body fluids (peritoneal, cerebrospinal) and urine, led to the 
proposition that cffDNA might be transported by concentration gradient (Al‐Yatama et al., 2001; 
Angert et al., 2004; Bianchi et al., 2001). 
Fetal trophoblast cells that enter the maternal side would likely be targeted by the maternal immune 
cells, thus releasing their DNA in the process. A study has demonstrated that around 80% of 
pregnant women may have a detectable amount of fetal DNA in their blood by 28 days of gestation. 
However, it takes 28-30 days to establish fetoplacental circulation post-conception (Guibert et al., 
2003). This finding along with an extremely rare occurrence of fetal hematopoietic cells in the 
maternal circulation strongly suggested that the predominant source of cffDNA was the 
trophoblast of the placenta rather than hematopoietic cells. Additionally, a strong positive 
correlation between human chorionic gonadotropin (hCG) concentrations and fetal DNA in 
maternal blood was found (Ohashi et al., 2002; Sekizawa, Sugito, et al., 2001). Furthermore, the 
presence of placenta-specific mRNA molecules in the plasma of pregnant women provided more 
convincing evidence that the placenta was the chief source of cffDNA (Ng et al., 2003). 
Subsequent studies confirmed that fetal trophoblast cells undergoing apoptosis are considered the 
most likely source of cffDNA in the peripheral circulation of the pregnant woman (Alberry et al., 
2007; Bischoff et al., 2005). These observations were further confirmed in mice through studies 
on placental explants as humans and rodents have similar placentation (Phillippe & Adeli, 2017). 
1.2.2.2. Placental (fetal-maternal interface) classification 
The placenta is a transient organ that is only present during pregnancy to facilitate the growth and 
development of the fetus in-utero. Although considered a feature of eutherian mammals, there has 
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been an ongoing discussion about the placenta being present in the late gestation of marsupials 
(Guernsey et al., 2017). Across different species, the placenta performs multiple functions that 
include nutrient and metabolite exchange between the mother and the fetus; hormonal secretion, 
physical and immunological protection of the fetus from pathogens and manage fetal excretions 
(Bauer et al., 1998; Burton & Fowden, 2015; Carter, 2012). Nonetheless, the placental organization 
varies between different species of animals (Enders & Blankenship, 1999). So, it is essential to 
consider the placental diversity before generalizing the endocrinological, physiological, 
immunological, and other data from animals to humans, especially in the transfer of biomolecules, 
drugs, and chemicals (Burton et al., 2006). 
During the early developmental stages, the yolk sac placenta (choriovitelline) provides the crucial 
support to the embryo till 11.5d of pregnancy (19-20d gestation) in mice (Malassiné et al., 2003), 
21d of pregnancy in dogs and humans (Freyer & Renfree, 2009; Malassiné et al., 2003), 30d in 
pigs (Friess et al., 1980) and up to 40-50 d in horses (Enders & Liu, 1991; P. Wooding & Burton, 
2008). In ruminant, the choriovitelline placentation may be absent or short-lived (few days) as the 
vascular part of the yolk sac is not observed to make contact with chorion (Carter & Mess, 2018). 
Except for rodents, the chorioallantois (vascular supply of chorion provided by vessels originating 
from allantois) is the primary form of the placenta through a significant part of pregnancy in 
humans and domesticated animals. The chorioallantois placentae have been classified primarily 
based on the gross morphological shape of the attachment site and histological structure at the feto-
maternal interface (Burton et al., 2006; Telugu & Green, 2007; P. Wooding & Burton, 2008). 
These classification systems and each category of the placenta are being discussed in the following 
subsections. 
Placental classification based on the gross shape 
This classification scheme for the placental type is based upon the organization of the villi or 
outgrowths of the surface of the outermost fetal membrane, i.e., chorion (King, 1992). Four types 
of placentae that have been recognized under this classification include diffuse, cotyledonary, 
zonary, and discoid. However, variations in different shapes have been observed and will be 





Equine (singleton and twins most common) and swine (polytocus species) have diffused placenta, 
characterized by the uniform distribution of chorionic villi across the placental surface (Allen & 
Stewart, 2001; Friess et al., 1980). Even though the equine placenta appeared overtly smooth, it 
had microvilli with secondary and tertiary branching patterns to form the “microcotyledons” that 
would attach to complementary invaginations in the uterus surface (Pozor, 2016). These microvilli 
connections would not be seen at the chorionic surfaces opposite the cervix and oviductal end of 
the uterine horns and in the folds that carry placental vessels (Pozor, 2016). In the case of swine, 
there is a complex folding of allantochorion forming ridges that get positioned over their respective 
crypts or grooves in the maternal endometrium (Friess et al., 1980). 
Cotyledonary placenta 
Both domesticated and wild ruminants of the Bovidae family have been observed to have the 
chorionic villi arranged in localized round or oval areas known as “cotyledon” (Carter, 2019; King, 
1992). The maternal sites for the attachment of cotyledons were identified as caruncles and the 
placental units were collectively called placentomes (Carter, 2019; King, 1992). Cows and small 
ruminants have dome or concave-shaped and cup or convex-shaped caruncles, respectively, 
usually arranged in rows (P. Wooding & Burton, 2008). The number of placentomes varies 
between species, 3-8 in deer and 20-150 in domesticated ruminants (Carter, 2019; P. Wooding & 
Burton, 2008). The localized placentation sites along with secondary and tertiary branching of the 
chorionic villi (that interdigitates into maternal crypts) in ruminants have been proposed to provide 
a concentrated vascular exchange per gram of fetal tissue (Baur, 1977). The average number of 
placentomes in cattle has been observed to increase from 10 to 80 between 35 d to 70 d of gestation 
(Assis Neto et al., 2010). The placentomes in growing heifers have been reported to be greater in 
number but have less surface area per cotyledon than the mature cows (Eetvelde et al., 2016). 
Additionally, the same study observed a seasonal variation in the cotyledon size, although the 
reason and physiological significance were not apparent. There are likely some compensatory 






Mainly elephants and carnivores (cats, dogs, wild canids, and felids) have the zonary or ring or 
belt-shaped placentation (Favaron et al., 2014; Leiser & Koob, 1993; Miglino et al., 2006; Ramsey, 
1975); however, a rare case of similar placentation has been reported in humans (Steemers et al., 
1995). Observed characteristics of the zonary placenta were an organization of the chorionic villi 
as a girdle in the center of the chorioallantoic sac, which was complete in dogs but incomplete 
about 2/3rd in the cats (Miglino et al., 2006). The chorionic girdle has a central broad transfer zone 
around the conceptus that serves as an important region of exchange of nutrients from the dam to 
a fetus, whereas the pigmented zone surrounding it is involved in the transport of iron. Another 
transparent zone presents distally on both the chorionic ends is responsible for absorbing 
substances directly from the uterus (Senger, 2003). 
Discoid placenta 
A single circular or disk-shaped placenta was observed in primates, rabbits, and rodents; however, 
variations have been reported in rhesus monkeys with a bidiscoidal placenta (King, 1992). The 
chorionic villi attachment was only observed in the localized circular zone on the chorioallantois 
and a corresponding region of the maternal placenta. The location of the placenta could be 
anywhere in the uterus except for the fundus, which might vary with the presence of multiple fetii 
(P. Wooding & Burton, 2008). 
Placental classification based on the histological structure 
The classification of mammalian placentae based on the number of layers (interhemal membrane) 
between the maternal and fetal blood was first proposed by Grosser in 1909 and has been 
considered the most informative regarding placental functionality (Grosser, 1909). The three 
primary forms of placenta have been recognized under this criterion of classification, which 







The epitheliochorial placenta has been considered the most superficial in terms of the contact 
between the maternal and fetal vascular components as all the six layers viz. uterine vascular 
endothelial lining, uterine connective tissue, uterine epithelial lining, chorionic cell layer, fetal 
connective tissue, and fetal endothelial cell lining, are intact. This type of placenta is found in 
mare, sow, and ruminants (although with some modifications). 
The equine epitheliochorial placenta is characterized by the temporary appearance of specialised 
structures called ‘endometrial cups’ that collectively arise from maternal endometrium and fetal 
trophoblast. These cups develop between 35-60 days post-conception and are 5-10 in number over 
the entire placental surface. These structures produce equine chorionic gonadotropin (eCG) 
hormone that forms accessory corpora lutea to maintain pregnancy and start disappearing after 60 
days post-conception (Senger, 2003). 
The swine placenta has a velvety surface with numerous tightly packed chorionic villi uniformly 
distributed above the entire chorion (Senger, 2003). The interhemal region of the placenta consists 
of fetal and maternal blood vessels that are present under the basement membrane of the 
trophectoderm and endometrium without any loss of the endometrial tissue (Leiser et al., 1998; 
Perry, 1981). The thin interhemal layer and rich supply of blood vessels reduce the distance for 
diffusion of substances between dam and fetus (Enders & Blankenship, 1999). 
Ruminant placentation was initially called syndesmochorial based on initial observations that the 
endometrial lining undergoes degeneration, and the chorionic epithelium and uterine connective 
tissue layers were in direct contact (King, 1992). Based on ultrastructural studies using electron 
microscopy in sheep, the ruminant placenta was observed to have synepitheliochorial placentation 
(F. B. P. Wooding, 1980, 1984). Based on these studies, the fetal trophoblast layer consisted of 
mononuclear and binuclear cells. The binucleate cells that first appear at the time of implantation 
would represent up to 20% of the trophectoderm cell population and secrete proteins and hormones 
(Nakano et al., 2001). Some fetal binuclear cells would translocate and undergo apical fusion with 
the uterine epithelial cells to form a syncytial layer, hence the name synepitheliochorium (Cornelis 
et al., 2013; F. B. P. Wooding, 1980, 1984). The syncytium consisted of mononuclear uterine 




The endotheliochorial placentation of carnivores featured a loss of uterine epithelium and 
connective tissue layers, leaving a four-layer thick interhemal membrane bringing maternal and 
fetal vascular supply closer (Barrau et al., 1975; Leiser & Koob, 1993; P. Wooding & Burton, 
2008). The trophectoderm cells were observed to fuse and invade the uterine epithelial layer, 
followed by necrosis of uterine epithelial cells and their phagocytosis by trophoblast cells (Barrau 
et al., 1975).  As the chorionic villi syncytium expanded, the hematoma was observed at the 
margins of the placental girdle, and the maternal capillaries system also reorganized to adapt to 
fetal nutrient requirements (Leiser & Koob, 1993; P. Wooding & Burton, 2008). In the case of 
elephants, the placenta is predominantly endotheliochorial with some scattered hemochorial 
regions (Ramsey, 1975). 
Hemochorial placenta 
Hemochorial placenta represents the most invasive type of placentation and has been observed in 
primates (hemomonochorial), rabbits (hemodichorial), rats and mice (hemotrichorial), with single, 
double, and triple trophoblastic layers, respectively (Steven, 1975; Takata et al., 1997). This type 
of placenta is characterized by the disappearance of all tissue layers on the maternal side and the 
fetal trophectoderm is in direct contact with the maternal blood (King, 1992).  
In primates, the placental villi are directly in contact with maternal blood. The outer surface of 
placental villi that bathes in maternal blood vessels is called syncytiotrophoblast, whereas the layer 
just beneath it is called cytotrophoblast (Enders & Blankenship, 1999). The stromal region of 
placental villi harbours fetal blood vessels. 
1.2.2.3. Comparative permeability of placenta between different animal species 
The primary purpose of the placenta is to transfer the nutrients from the dam to the fetus while 
simultaneously performing several secretory and regulatory tasks necessary for pregnancy 
maintenance. Most of the biomolecules traverse the placenta through the phenomenon of simple 
diffusion, active transport, and/or facilitated transport (Furukawa et al., 2014). In the instance of 
simple diffusion, the thickness of the cellular/tissue barrier between fetal and maternal blood 
(interhemal distance) would be the predominant factor influencing the ability of the molecules to 
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pass through the placenta. The biomolecules will diffuse through the placenta more efficiently if 
the interhemal membrane is less thick. Similarly, the rate of active and facilitated transport would 
also be influenced by the thickness of interhemal distance. Hence, the histological structure of the 
placenta (i.e., the layers separating maternal and fetal blood) strongly determines the transfer of 
biomolecules through the feto-maternal interface (Mihaly & Morgan, 1983; Miller et al., 1976; 
Père, 2003). As a result, the biomolecules (such as fatty acids and keto acids) might move rapidly 
from mother to fetus and vice-versa in primates, rabbits, and rodents (hemochorial placenta); 
however, their transfer across the placenta may be limited in ruminants, mare, and sow (Père, 
2003). 
1.2.2.4. Diagnostic importance of cffDNA 
Since its discovery, the cffDNA has been used for prenatal screening for fetal sex, fetal blood-
group antigens, and chromosomal abnormalities. Initial studies described the usefulness of 
cffDNA as a non-invasive tool for fetal sex determination in pregnant women (Dennis Lo, Tein, 
et al., 1998; Sekizawa, Kondo, et al., 2001). The sex determination was based upon the detection 
of Y chromosome-specific sequences where the presence of the Y sequence corresponds to the 
male fetus while its absence corresponds to the female fetus. Most commonly targeted Y-
chromosome sequences using PCR included a single locus DYS14 gene (Dennis Lo et al., 1990), 
a single locus sex-determining region of Y-chromosome (SRY) gene (Shah & Smart, 1996), and 
a multilocus deleted in azoospermia (DAZ) genes (Stanghellini et al., 2006). Further, the cffDNA 
was used to screen the fetus for X-linked disorders viz hemophilia and Duchenne muscular 
hypertrophy in pregnant women that were a carrier for these diseases (Breveglieri et al., 2019). 
Additionally, the extracted cffDNA has been applied to detect fetal Rhesus D (RhD) blood type in 
pregnant women that were RhD negative (Dennis Lo, Hjelm, et al., 1998); aneuploidies viz. 
trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome), and trisomy 21 (Down syndrome) 
(Mennuti et al., 2015; Skrzypek & Hui, 2017); microduplications, microdeletions, and genetic 
diseases occurring due to mutations that followed paternal-specific inheritance (Bianchi, 2012; 
Ferrari et al., 2015). 
Although much research on cffDNA has focused on prenatal diagnostics in women, this 
technology is still in the nascent stages in the case of bovine. Few studies have suggested that 
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cffDNA could be used for prenatal fetal sex determination in pregnant cattle (Da Cruz et al., 2012; 
Ristanic et al., 2018). 
1.2.2.5. Challenges in fetal sex determination using cffDNA 
Since the maternal cfDNA would exceed the fetal fraction in maternal blood samples, amplifying 
cffDNA has been challenging (Wright & Burton, 2009). In humans, a minimum of 2-4% fetal 
fraction of cfDNA has been suggested in the maternal blood that would be required for obtaining 
reliable results following prenatal assays (Ashoor et al., 2013; Canick et al., 2013; Fan & Quake, 
2010; Hui & Bianchi, 2020). The lower concentrations of cffDNA in maternal circulation would 
potentially increase the false-negative or no-call results (Wataganara et al., 2016). However, 
methods such as high depth sequencing would likely compensate for the low yield of cffDNA, but 
at added costs. Various factors have been observed to be associated with changes in the fetal 
fraction of the cfDNA in the maternal blood of pregnant women, which could affect the results of 
prenatal testing. For instance, fetal fraction rises with an increase in gestational age (Kinnings et 
al., 2015), crown-rump length (Ashoor et al., 2013), multiple pregnancies (Hedriana et al., 2020), 
and serum-free hCG concentration (Ashoor et al., 2013; T. J. Lee et al., 2018). In contrast, fetal 
fraction decreases in case of mosaicism (Brison et al., 2018), triploidy (Nicolaides et al., 2014), 
increase in maternal weight (Ashoor et al., 2013), maternal autoimmune disease (Hui et al., 2014), 
animals bred by assisted reproductive techniques (T. J. Lee et al., 2018). 
Additionally, we can expect even further lower quantities of circulating cffDNA in the plasma of 
pregnant cows than pregnant women, considering the presence of more tissue layers at the 
placental interface in bovines. 
1.2.2.6. Size of fetal versus maternal cfDNA sequences 
Several studies using Y-chromosome have confirmed that cffDNA has a shorter base-pair length 
than maternal cfDNA. The first study comparing fetal and maternal cfDNA sequences using 
fluorescent PCR reported that the size of cffDNA sequences was usually < 300 bp, whereas the 
maternal cfDNA was >1000 bp (Li et al., 2004). The authors further proposed that cffDNA might 
be enriched based on the size selection with a 300 bp length threshold. Other reports indicated that 
the median length of maternal cfDNA was approximately 500 bp, while the significant proportion 
of the cffDNA was <300 bp (K. C. A. Chan et al., 2004; Li et al., 2004). In contrast, a subsequent 
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study showed that the length distribution of cffDNA differs from that of maternal cfDNA as an 
enhanced proportion of cffDNA fragments shorter than 150 bp are found in maternal plasma, 
which possibly exists because of the differential nucleosomal packaging during the complex 
process of apoptosis or the difference in the nucleosome binding force (Fan et al., 2010). Although 
the cffDNA is significantly shorter than maternal cfDNA, cffDNA increases in size as the 
pregnancy advances (K. C. A. Chan et al., 2004). 
1.2.3. Assessment of cfDNA 
Although much research has been conducted in cfDNA diagnostics in the past few decades, only 
a few cfDNA based clinical tests have found their way even in human medical practice. One of 
the main reasons behind the slow adoption of research to the lab is the lack of standard operating 
procedures, as cfDNA extraction and quantification protocols have evolved and significantly differ 
between laboratories. Additionally, there has been a lack of consensus on the sample type, sample 
handling, storage conditions, and their effects on concentration and fragmentation of cfDNA (El 
Messaoudi et al., 2013). The following subsections will discuss different factors that could affect 
the yield of cfDNA from the peripheral circulation. 
1.2.3.1. Sample type, anticoagulants, and collection vials 
Several studies on the paired serum and plasma samples have demonstrated significantly lower 
cfDNA concentrations in plasma than serum (T. H. Lee et al., 2001; Umetani et al., 2006). The 
serum cfDNA concentrations were reportedly 1.63 to 11-fold higher than the plasma in healthy 
individuals (K. A. Chan et al., 2005; Ginkel et al., 2017). Similarly, the serum samples from cancer 
patients had an 11-fold higher concentration of cfDNA than their plasma samples (Park et al., 
2012). Based on the ratio of 201/105 bp amplicons following qPCR for leptin, higher integrity of 
the cfDNA was noted in serum (50%) than plasma (33%) (K. A. Chan et al., 2005; Holdenrieder 
et al., 2008). These remarkably higher cfDNA concentrations with better integrity in serum were 
attributed to the release of genomic DNA from leukocytes undergoing lysis during the clotting 
process (K. A. Chan et al., 2005; Lam et al., 2004; T. H. Lee et al., 2001). In order to avoid further 
contamination and dilution of the fetal fraction of cfDNA, plasma samples have been preferred 
over the serum samples for the extraction of cffDNA for downstream diagnostic assays in humans 
(Fernando et al., 2010; Meddeb et al., 2019). 
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As multiple anticoagulants are available to harvest plasma from blood samples, it is essential to 
determine the anticoagulant suitable for the stability of cfDNA. Several studies that compared 
citrate, ethylenediaminetetraacetic acid (EDTA), and heparin as anticoagulants identified EDTA 
as the preferred anticoagulant, while heparin was observed to affect downstream processing by 
causing PCR inhibition (Beutler et al., 1990; Jung et al., 1997). Further, plasma collected using 
EDTA vials could still be used, even if the processing of blood samples was delayed up to six 
hours (Lam et al., 2004). Storage of blood samples in potassium EDTA vials beyond six hours 
under refrigeration had been associated with a gradual increase in total cfDNA due to the release 
of longer DNA fragments from cell lysis, while the cffDNA content did not change (Barrett et al., 
2011; Page et al., 2011). As a result, there was a reduction in the relative proportion of cffDNA 
(Barrett et al., 2011; Page et al., 2011).  
Nevertheless, to avoid the immediate need for blood processing, special tubes for blood collection 
have been introduced containing specific preservatives to stabilize the blood leukocytes for 
extended periods. Blood samples taken from pregnant women and stored at room temperature for 
one week in the cell stabilizing tubes showed no change in the concentration of total cfDNA over 
time, while the samples stored in EDTA tubes under the same conditions showed an increase in 
cfDNA after 24 h (Fernando et al., 2010; Wong et al., 2013). During the storage period, the fetal 
copy number remained stable between the type of tubes; however, the fetal fraction decreased after 
24 h in the EDTA tubes due to an increase in long maternal DNA fragments (Wong et al., 2013). 
Based on the American Association for Clinical Chemistry (AACC) recommendations, the 
samples collected in EDTA tubes kept at room temperature need to be processed within four h or 
24 h of collection if kept under refrigeration. In contrast, the samples collected in specialized tubes 
might be kept for 5 d at room temperature before processing (Meddeb et al., 2019). 
1.2.3.2. Handling, storage, and processing of samples before DNA extraction 
The AACC recommends proper mixing of blood samples in collection tubes, screening blood 
samples for hemolysis and avoiding their use if the hemolysis is present (Meddeb et al., 2019). 
Some studies have indicated an increase in cfDNA following shaking of blood samples or repeat 
passaging of blood samples through small gauge needle (El Messaoudi et al., 2013; Nishimura et 
al., 2019). However, a recent study on a larger number of human samples found no correlation 
between the observed hemolysis and relative proportions of cfDNA (Stokowski et al., 2020). Since 
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adult RBC are non-nucleated, their lysis may only release RNA, not affecting cfDNA 
concentrations. However, the hemolyzed samples may be associated with the release of PCR 
inhibitors. 
One of the critical preanalytical steps is centrifugation of the collected blood to separate cells from 
plasma. Centrifugation of blood at low speed (800×g) for 10 min resulted in increased cfDNA 
compared to a higher rate (16000×g) for the same time (Chiu et al., 2001). Further, two-step 
centrifugation was found to be more efficient for downstream processing of plasma for cfDNA 
extraction (Chiu et al., 2001). Some studies have argued against the need for double centrifugation 
(Trigg et al., 2018). However, the currently recommended procedure of plasma separation for 
human samples by the AACC includes centrifugation under refrigeration either at 800-1200×g (10 
min at 4°C) followed by 16000×g (10 min at 4°C) or two serial centrifugation at 1600×g and 
16000×g (10 min each at 4°C), respectively (Meddeb et al., 2019). 
1.2.3.3. Repeated plasma freeze-thaw cycles and cfDNA yield 
A significant decline in the integrity of cfDNA was observed every time plasma was subjected to 
freeze-thaw cycles, which showed that cfDNA was sensitive to temperature variations and got 
fragmented when plasma was repeatedly frozen and thawed (K. A. Chan et al., 2005). The same 
findings have also been replicated by El Messaoudi and co-workers, who have confirmed the 
sensitive nature of plasma cfDNA to the variations in temperature (El Messaoudi et al., 2013). As 
per the guidelines of AACC, plasma should not be subjected to more than two freeze-thaw cycles 
before DNA extraction to avoid the deterioration of cfDNA integrity (Meddeb et al., 2019). 
1.2.4. Extraction protocols for cfDNA from plasma 
Beyond the conventional protocols, a wide range of DNA extraction methodologies could be used 
for cffDNA isolation and downstream assays. The conventional protocols are cost-effective and 
could be modified as per the available laboratory facilities; however, they would be labor-intensive 
with increased turnaround times and variability (Bronkhorst et al., 2015; McKiernan & Danielson, 
2017). The new commercial specialized kits are costly but have standardized protocols to enhance 
repeatability, facilitate automation and increase cfDNA yield (Trigg et al., 2018). The standard 
DNA extraction protocols are being discussed in upcoming subsections. 
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1.2.4.1. Silica based spin-column protocols 
These commercial kits are based on the salt-dependent binding of DNA in the sample to the silica 
resin present in the spin columns and involve the following steps. The plasma/serum samples are 
treated with a buffer to lyse cells and proteinase-K for protein digestion. The buffer would also 
assist in attaching DNA to the silica-gel membrane in the spin column and remove enzyme 
inhibitors and other contaminants. Furthermore, the PCR inhibitory substances viz. proteins and 
divalent cations are eliminated in highly efficacious two-three washing steps. As a result, the pure 
nucleic acids left behind with the silica membrane are ultimately eluted in the elution buffer. A 
study comparing the cffDNA extraction efficiencies of QIAamp® Circulating Nucleic Acid Kit 
(Qiagen, Valencia, CA) and QIAamp® DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA) found 
no differences in the cffDNA yields between these two kits (Manokhina et al., 2014). A recent 
study comparing QIAamp® DSP Virus Kit (Cat. No. 60704; Qiagen, Germany) and QIAamp® 
Circulating Nucleic Acid Kit (Cat. No. 1017647; Qiagen, Germany) obtained significantly higher 
cffDNA yields from the DNA extracts of QIAamp® Circulating Nucleic Acid Kit (Jain et al., 
2019). 
1.2.4.2. Magnetic beads-based protocols 
As the name suggests, these kits are based on the selective binding of DNA to magnetic beads, 
which provide more surface area to make it more efficient in terms of DNA yield with minimum 
variations (Jorgez et al., 2006). Most magnetic beads-based DNA extraction kits comprise four 
extraction steps: lysis, binding (to magnetic beads), washing (2-3x), and elution. Examples of 
magnetic kits include the NucleoMag® Cell-Free DNA Kit (Cat. No. 744550.1; Macherey-Nagel, 
Germany) and MagMAX™ Cell-Free DNA Isolation Kit (Cat. No. A29319; Applied Biosystems, 
USA) suitable for both manual and automated platforms. Studies have reported that magnetic 
beads provide higher yields of plasma cfDNA in human lung and colon cancer patients (Stemmer 
et al., 2003) and cffDNA in pregnant women compared to other column-based and conventional 
DNA extraction methods (Jorgez et al., 2006). 
1.2.4.3. Other protocols 
Phenol chloroform-based methods and salting-out protocols are the most common traditional 
techniques for cfDNA extraction from plasma/serum samples (Bronkhorst et al., 2015). Phenol 
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chloroform-based DNA extraction involves using proteinase K and sodium dodecyl sulfate (SDS) 
for the enzymatic dissolution of cellular and protein components of the sample. After this, the 
sample is treated with a combination of equilibrated phenol: chloroform: isoamyl alcohol (25:24:1) 
which promotes the separation of the organic phase (containing cellular debris and lipids) from the 
aqueous phase (containing nucleic acids). The aqueous phase that contains the purified nucleic 
acids is then transferred to a new centrifuge tube for further analysis following centrifugation. 
Alternatively, the nucleic acids in the aqueous phase can also be recovered by ethanol precipitation 
or concentrated through centrifugal filter units (Comey et al., 1994; McKiernan & Danielson, 
2017). However, the phenol-chloroform extraction method uses hazardous chemicals, and 
involves a substantial manual effort. In addition, the chances of sample mishandling and 
contamination are significantly increased because of the involvement of multiple tube transfer 
steps (Köchl et al., 2005). Another fundamental limitation of the phenol-chloroform method is the 
carry-over of phenol and other PCR inhibitors in the isolated DNA sample that significantly 
compromise the downstream processing (Lemarchand et al., 2005), thereby increasing the chances 
of false-negative results in the PCR. Many variations of phenol-chloroform protocol have been 
used for extraction of cfDNA in several research studies in humans involving cancer diagnostics 
(Elshimali et al., 2013; Hufnagl et al., 2013; Xue et al., 2009), parasitic diagnosis (Wichmann et 
al., 2009), and evaluation of ageing biomarkers (Jylhävä et al., 2011). Furthermore, the phenol-
chloroform protocol has also been used to extract cffDNA in the studies focusing on PCR-based 
prenatal fetal sex determination in cattle (Davoudi et al., 2011; Ristanic et al., 2018) and sheep 
(Kadivar et al., 2013). 
Another conventional method, the salting-out protocol, was used to extract cfDNA for fetal sex 
determination in cattle (Lemos et al., 2011). In this method, lysis of the blood cells is performed 
using lysis buffer until a clean pellet is obtained. Then, proteinase K and SDS are added for the 
enzymatic dissolution of cellular and protein components of the sample. Subsequently, the sample 
is treated with a saturated solution of NaCl for the precipitation of proteins. The supernatant is then 
treated with absolute ethanol to precipitate DNA which is eluted after washing it with 70% ethanol 
(Shokrzadeh & Mohammadpour, 2018). As this protocol uses whole blood to extract cfDNA, the 
chances of contamination with genomic DNA from maternal blood cells are high. A different 
throughput method involves using a novel buffer system and a thermostable protease (KAPA 
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Express Extract Kit®, Cat No. KK7100; KAPA Biosystems, South Africa) to extract genomic 
DNA from blood and tissue samples.  
The majority of these methods have been developed for human samples; however, some studies 
have used different kits to assess cffDNA for fetal sex determination in cattle (Da Cruz et al., 2012; 
Ristanic et al., 2018; G. Wang et al., 2010). Various methodologies that have been used for cffDNA 
extraction for prenatal fetal sex determination have been summarized in Table 1.2. 
1.2.5. Storage of extracted cfDNA and freeze-thaw cycles 
For human samples, the AACC suggested that cfDNA extracts may be stored for 3 h at room 
temperature, 24 h at 4°C, and 3 months to 10 years at -20°C to -80°C (Meddeb et al., 2019). 
Furthermore, it had also been shown that cffDNA in the plasma would deteriorate after the third 
freeze-thaw cycle (K. A. Chan et al., 2005; Meddeb et al., 2019). 
1.3. Status of prenatal fetal sex determination in domestic and wild animals using 
cffDNA 
Various studies have targeted cffDNA using molecular methods in the maternal plasma of pregnant 
wild and domestic animals to ascertain the sex of the fetus before birth. The following subsections 
summarize the successes and limitations of using PCR for prenatal fetal sexing in animals with 
endotheliochorial and epitheliochorial placentation. We have excluded primates and rodents, with 
hemochorial placentation, from the discussion. 
1.3.1. Animals with endotheliochorial placenta 
Since both dogs and cats carry multiple fetii during each pregnancy, the use of PCR for fetal sexing 
would be the least practical due to the challenge of differentiating fetii of different sexes based on 
PCR. As a result, ultrasound seems to be the feasible approach to determine fetal sex if at all the 
breeders would be interested (Prugnard et al., 2016). Elephants that share the placental morphology 
and histoarchitecture with carnivores have been studied recently to detect fetal sex using PCR 
(Vincze et al., 2019). Two sets of primers utilized in this study were to target SRY and AMEL 
(Amelogenin), while PlpX (proteolipid protein) specific for X-chromosome was used as a control. 
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Elephants were sampled four times between 80-86 weeks of gestation and plasma was processed 
for conventional PCR, the results of which matched with the fetal sex (summarized in Table 1.2). 
1.3.2. Animals with epitheliochorial placenta 
The horses are another species that has diffused epitheliochorial placenta and usually have 
singleton or rarely twin births. Recently, a couple of studies on a smaller number of mares have 
aimed at evaluating the usefulness of determining fetal sex in pregnant mares. In an initial study, 
plasma samples from thoroughbred mares in the last trimester of pregnancy were tested for SRY 
using two rounds of conventional PCR (de Leon et al., 2012). Based on the first PCR, the sex was 
accurately determined in 17/20 mares, whereas the accuracy was 95% (19/20) following the 
second round of PCR. In a subsequent study, blood samples were taken from 32 pregnant mares 
during each trimester of gestation, PCR was performed to target the SRY gene and results were 
compared with the sex of foals at birth (Tonekaboni et al., 2020). A gradual increase in accuracy 
of PCR for fetal sexing was observed as the gestation advanced (49%, 69% and 75% for 1st, 2nd, 
and 3rd trimester of pregnancy, respectively). Another study on Arabian mares (n=50) with a single 
fetus reported a higher accuracy (93%) using a duplex real-time PCR targeting SRY and TSPY 
sequences (Kadivar et al., 2021). The sensitivity and specificity of duplex PCR were 90% and 
96%, respectively. A summary of all these studies in mares has been presented in Table 1.2. 
Rhinoceros, another species with diffused epitheliochorial placenta, has also been studied 
regarding prenatal fetal sexing using PCR (Stoops et al., 2018). Serum from pregnant rhinoceros 
(n=14) in varying stages of gestation (61-490 days range) was tested using primers targeting SRY 
and equine AMEL (Amelogenin) genes. The authors reported that both DNA concentrations and 
PCR amplification were significantly reduced when frozen-thawed serum samples were used to 
determine fetal sex. In contrast, when they used fresh serum samples for DNA extraction, the first 
round of PCR provided a 71% accuracy of SRY gene amplification for pregnancies carrying male 
fetii. This accuracy increased to 100% when the first-round PCR products were used for the second 
round of PCR. However, no SRY products were obtained in either round of PCR when samples 
from female pregnancies were used (summarized in Table 1.2). 
Amongst the ruminants, which have cotyledonary and synepitheliochorial placenta, sheep and 
cattle are the most studied species for prenatal sex determination using PCR. The findings of 
different studies have been briefly discussed below and summarized in Table 1.2. 
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Kadivar and co-workers performed the first study on PCR-based prenatal fetal sex determination 
in pregnant ewes (n=46) in 60-150 days of gestation. A pair of primers targeting SRY sequence 
and yielding a 286 bp PCR product from the male fetal genome was used to determine fetal sex. 
At the same time, another set of primers targeting the GAPDH gene and yielding a 467 bp PCR 
product was used as an internal control. The PCR-based fetal sex results were compared with the 
sex of the offsprings at birth. The qPCR methodology used in this study correctly predicted 31/31 
male and 15/15 female fetuses with an overall accuracy of 100%. Furthermore, the authors also 
showed a significant rise in the levels of fetal DNA with advancement in gestation, and fetal DNA 
concentrations were found to be 1.65-fold higher in the last two months of pregnancy compared 
to the first three months (Kadivar et al., 2013). 
Kadivar and co-workers conducted another experiment to determine ovine fetal sex prenatally 
using AMELY (Amelogenin-Y) primers. They included 45 pregnant Lori-Bakhtiari sheep 56-126 
days in gestation in their study. A pair of AMELY primers were designed to amplify a 111 bp 
product out of the Y-chromosome of male fetuses while simultaneously incorporating an internal 
control that amplified a 467 bp sequence out of the GAPDH gene irrespective of the fetal sex. The 
PCR-based fetal sex results were verified with the sex of the offsprings at birth. They reported that 
the qPCR methodology used in their study correctly predicted 27/28 male and 15/17 female fetuses 
while 1/28 and 2/17 fetuses were wrongly predicted as female and male, respectively. The overall 
accuracy of this PCR-based ovine fetal sexing methodology was 93.3%, whereas the sensitivity 
and specificity of the test were 96.5% and 87.5%, respectively (Kadivar et al., 2015). 
Asadpour and co-workers also performed PCR-based prenatal fetal sex determination in 32 
pregnant ewes (42-147 days in gestation), with 15/32 carrying male and 17/32 carrying female 
fetuses confirmed at parturition. The primer set utilized in this study amplified a 217 bp and a 280 
bp amelogenin gene sequence from the Y and X chromosomes, respectively. When PCR-based 
fetal sexing outcome was compared with the sex of the offsprings at birth, the PCR methodology 
was found to yield an overall accuracy of 78% with 12/15 and 13/17 correct male and female fetus 
predictions, respectively. However, 3/15 male fetuses and 4/17 female fetuses were wrongly 
predicted female and male, respectively, by the PCR assay (Asadpour et al., 2015). 
Kadokawa and co-workers conducted a research study to evaluate the presence of fetal nucleic 
acids in bovine maternal circulation. For this purpose, they collected blood samples from the 
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jugular and uterine veins of 3 pregnant cows (2 carrying male fetuses; 1 carrying female fetus) in 
84-140 days of gestation. In addition, they also collected blood samples from the jugular vein of 
33 pregnant cows (18 carrying male fetuses; 15 carrying female fetuses) in 70-280 days of 
gestation. They performed DNA extraction from all these blood samples and carried out a PCR 
targeting Y-specific repeat sequence (btDYZ). Simultaneously, another primer set was also used 
to target the β-actin gene that served as an internal control. The PCR result showed no 
amplification of male-specific DNA sequence in any of the samples irrespective of the site of blood 
sampling. The authors thus concluded that fetal DNA might not be present in the adequate levels 
in maternal circulation. Therefore, blood from the pregnant cows could not be used for PCR-based 
prenatal fetal sexing (Kadokawa et al., 1996). 
Xi collected blood samples from pregnant dairy cows (n=32) in 30-240 days of gestation for PCR-
based prenatal fetal sex determination. Their PCR methodology involved targeting Y-
chromosome-specific SRY gene sequences to identify male fetuses. In addition, they used a primer 
set to amplify the β-actin gene sequence irrespective of the fetal sex to serve as an internal control. 
When the DNA isolated from the plasma of these pregnant cows was used as a PCR template, an 
80% overall accuracy of correctly identifying the fetal sex was reported. The author also noted that 
the accuracy of fetal sex prediction increases with advancement in gestation. The accuracy rates 
of 60%, 85.7%, and 92.3% were observed respectively for cows that were 30-60 days, 61-120 
days, and 121-240 days pregnant (Xi, 2006). 
Turin and co-workers conducted an experiment to determine the transplacental leakage of fetal 
genetic material to the maternal circulation in pregnant cows. The study was based upon the 
hypothesis that the epitheliochorial placenta of cows is least invasive and thus poses a barrier to 
the transfer of fetal cells/nucleic acids to the maternal circulation, unlike in primates. In this study, 
16 pregnant cows carrying male fetuses were included, and the blood samples were collected at 
four different time points viz. mid-gestation (150 days of pregnancy), pre-calving (260 days of 
pregnancy), calving (within 2 days following calving), and post-calving (4 months after calving). 
DNA was extracted from these blood samples followed by qPCR targeting Y-chromosome-
specific gene sequences to identify the male fetuses. Simultaneously, a set of primers targeting the 
b-actin gene sequence was also used in PCR as an internal control. Y-specific sequences were 
successfully amplified in 25% of cows during mid-gestation, 40% of cows at pre-calving, 73% 
cows at calving, and 40% of cows at post-calving. The authors thus concluded that although the 
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transplacental leakage of fetal genetic material to the maternal circulation occurs variably to a 
certain degree during pregnancy, the predominant transfer of fetal genetic material to the maternal 
circulation occurs during parturition. The authors also reported that irrespective of the stage of 
gestation or calving, as mentioned earlier, there are many occasions when fetal DNA is detected 
at one time point but absent in the subsequent samples. This finding indicated that the 
transplacental leakage of fetal genetic material to the maternal circulation might occur transiently 
and is not consistent throughout gestation (Turin et al., 2007). 
Wang and co-workers carried out research to determine the feasibility of prenatal fetal sex 
determination in pregnant cows using a nested PCR methodology targeting SRY gene sequences 
in the male fetal genome. The blood samples were collected from 110 pregnant cows (30-242 days 
in gestation), and plasma was harvested for DNA extraction. The overall accuracy of correctly 
identifying fetal sex was 100% (43/43) for male fetuses and 91% (61/67) for female fetuses. 
Furthermore, the accuracy rate of correctly identifying male and female fetuses in the 30-59 days 
pregnant cows was 100% (3/3) and 85.7% (12/14), respectively. However, after 60 days of 
gestation, the accuracy rate for male and female fetus prediction was 100% (40/40) and 92.5% 
(49/50), respectively (G. Wang et al., 2010). 
Lemos and co-workers conducted an experiment to detect the presence of fetal DNA in the 
peripheral blood circulation of pregnant cows. They collected blood from 84 primiparous Bos 
indicus cows in 30-270 days of gestation. The blood samples were used for DNA extraction, 
followed by a conventional PCR targeting TSPY (testes specific Y-encoded protein) gene 
amplifying a 260 bp product in the male fetal genome. The PCR identified 47/84 as the male 
fetuses and 37/84 as female fetuses. These PCR results showed a 100% match to the sex of the 
fetuses at birth. The authors, therefore, reported the presence of detectable levels of fetal DNA 
throughout the pregnancy in cows (Lemos et al., 2011). 
Davoudi and co-workers performed a study on PCR-based prenatal fetal sex determination in 
pregnant cows (n=38) between 56-266 days of gestation. They used two sets of primers in this 
study. The first primer set targeted bAML (bovine amelogenin) gene that amplified a 341 and 467 
bp product from bovine Y and X chromosomes, respectively. The second primer set targeted the 
TSPY gene that amplified a 260 bp product from the Y-chromosome of the male fetus. The PCR 
methodology used in this study predicted 24 cows to be carrying male fetuses and 14 cows to be 
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having female fetuses. The PCR-based fetal sex exactly matched the sex of the offspring in all 38 
pregnancies. The accuracy of this methodology was hence reported to be 100%, with no false 
positives and negative results (Davoudi et al., 2011). 
Da Cruz and co-workers performed prenatal fetal sex determination in 35 mixed-breed pregnant 
cows between 35-238 days of gestation using conventional PCR. They used two sets of primers 
targeting Y-chromosome-specific sequences in male fetal genome amplifying 210 and 196 bp 
products while simultaneously incorporating a primer set targeting an autosomal sequence of 280 
bp from chromosome-1 of cows. Overall, the fetal sex predicted by PCR accurately matched with 
fetal sex at birth in 31/35 cases yielding an accuracy rate of 88.6%. There was a 63.6% concordance 
of fetal sex predicted by PCR to the fetal sex at birth in 35-48 days pregnant cows, whereas it was 
100% on 49 days and onwards. As per the regression analysis, the PCR methodology showed an 
accuracy rate of 95%, 99%, and 99.9% at 43.8, 48.4, and 55 days of gestation, respectively (Da 
Cruz et al., 2012). 
Ristanic and co-workers performed a similar study in pregnant cows to assess the accuracy of this 
PCR-based non-invasive genetic fetal sex determination technique. They enrolled 40 pregnant 
Holstein Friesian cows and divided them into two groups. The first group comprised 55-90 days 
pregnant cows, while the second group consisted of 240-270 days pregnant ones. The fetal sex of 
first and second group cows was examined using ultrasonography and at birth, respectively. 
Group-1 cows carried ten male and ten female fetuses; however, group-2 cows had twelve male 
and eight female fetuses. For conventional and qPCR, primers and PCR conditions as described 
by Davoudi et al (2011) were used. With conventional PCR, 9/10 male and 10/10 female fetuses 
in group-1 were correctly predicted. In group-2, none of the male fetuses could be detected by the 
conventional PCR. In contrast, qPCR successfully predicted 9/10 and 11/12 male fetuses in group-
1 and 2, respectively. The authors thus reported that qPCR is more sensitive in amplifying the 
extremely low levels of fetal DNA than conventional PCR (Ristanic et al., 2018). 
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1.4. Objectives and hypotheses 
• The overall aim of this thesis was to establish a protocol for PCR-based prenatal sex 
determination in cattle. The specific objectives and hypothesis of this study were: 
1.4.1. Determine sample processing and DNA extraction protocol for PCR based prenatal 
fetal sex determination in pregnant cows 
1.4.1.1. Specific objectives 
• To determine the effect of stored and freshly collected plasma on cffDNA extraction and 
downstream PCR for fetal sexing. 
• To compare different DNA extraction methods on downstream PCR for fetal sexing in 
cattle. 
1.4.1.2. Hypothesis 
• We hypothesized that plasma storage, DNA extraction methods, and target genes would 
differentially affect the PCR results for fetal sex determination. 
1.4.2. Determination of the lower limits of cell-free fetal DNA in bovine plasma samples 
for PCR detection 
1.4.2.1. Specific objectives 
• To test the lowest limits of spiked cffDNA that can be re-extracted and amplified with PCR 
to identify bAML and Y-specific amplicons. 
• To determine the efficacy of the PCR-based prenatal sexing in cattle at different stages of 
gestation. 
• To compare three different commercial kits for extraction of cffDNA from spiked and neat 
plasma samples of pregnant cows.  
1.4.2.2. Hypotheses 
• cffDNA is low and variable in the plasma of pregnant cows, making it challenging to 
extract for conventional PCR. 
• cffDNA can be successfully extracted and amplified using conventional PCR if present at 




2. DETERMINE SAMPLE PROCESSING AND DNA EXTRACTION PROTOCOL 
FOR PCR BASED PRENATAL FETAL SEX DETERMINATION IN PREGNANT 
COWS 
2.1. Abstract 
Objectives: The overall aim of this study was to establish a protocol for PCR-based prenatal fetal 
sex determination in pregnant cows. Our specific goals were to a) determine the effect of frozen 
and fresh plasma on cffDNA extraction and PCR for fetal sexing and b) compare different DNA 
extraction methods on downstream PCR for fetal sexing in cows.  
Materials and methods: The current study included three trials. In the Trial 1, frozen samples from 
cows (n=15, three replicates, 120-150 days pregnant, each carrying a male fetus) were processed 
using three different DNA extraction methods followed by PCR. In the Trial 2, cfDNA from fresh 
plasma samples of pregnant cows (n=6, 120-150 days, each carrying a male fetus) was extracted 
by the phenol-chloroform method and used for PCR-based fetal sexing. In the first part of the Trial 
3, fresh plasma samples of pregnant cows (150-240 days; n=5 carrying male fetii, n=3 carrying 
female fetii) were used for DNA extraction (three methods) and PCR. In the second part of the 
Trial 3, fresh plasma samples and blood (for salting-out protocol) from five pregnant cows (150-
240 days pregnant; each carrying a male fetus) were processed for DNA extraction (seven different 
methods) followed by PCR.  
Results: None of the samples yielded male fetus-specific PCR products in our Trial 1, although 
sequence specific to maternal cfDNA was amplified in all instances. Neither an increase in the 
plasma volume for DNA extraction nor template DNA volume changed the results. In the Trial 2, 
we observed amplification of fetal DNA sequences in 5/6 cows when 10 µl of DNA extract was 
used for the PCR. In the first part of the Trial 3: upon bAML PCR, correct prediction of fetal sex 
was observed in 4/8, 4/8, and 2/8 DNA samples obtained by Dneasy Blood & Tissue Kit, 
MagMAX cfDNA Isolation Kit, and Phenol-chloroform method, respectively. In the second part 
of the Trial 3, male fetal gene sequences were successfully amplified in 3/5 samples (DSP Virus 
Kit), 2/5 samples each (Blood & Tissue Kit, MagMAX Kit, Nucleomag Kit, Salting-out protocol), 
and 0/5 samples (Midi Kit, KAPA Kit) in PCR.  
Conclusions:  Fresh plasma samples but not frozen from pregnant cows could be used for cfDNA 
extraction and PCR for fetal sexing. Further, DNA extraction methodologies compared in the 
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present study showed variability in their ability to isolate fetal DNA from maternal plasma/blood 
of pregnant cows. Therefore, the currently tested PCR assay was observed to be unreliable for 
prenatal fetal sexing in pregnant cattle and was not better than the chance prediction of 50%. 
2.2. Introduction 
Knowledge of the sex of the fetus before birth at the time of pregnancy diagnosis has multiple 
benefits for cow-calf operations. Specifically, by knowing the sex ratio of the future calf-crop, 
producers would plan for the replacement herd (based on expected female calves) and the expected 
number of steers that would be available for feedlots. Furthermore, purebred producers might 
retain the cows carrying bull calves based on their interest in their genetics for their herds or sale. 
Amongst the available tools to determine the sex-ratio of calf-crop, sex-sorted semen, and sexed 
embryo would be best fitted for seed stock producers and least likely to be adopted by the 
producers using natural breeding (Holden & Butler, 2018). Ultrasonography, which is used for 
pregnancy diagnosis at least in some herds, is another method for accurate detection of fetal sex 
between 55-70 days post-conception (Curran et al., 1989; Kamimura et al., 1994) and could be 
used until 100 d of gestation (Heyman et al., 2002). However, in some herds, this time window 
would be outside the usual three to five months of gestation when cattle are often diagnosed as 
pregnant at the time of fall pregnancy check. Further, ultrasonographic examination for fetal sexing 
needs additional time and expertise, limiting its applicability. The accuracy of fetal sexing 
decreases beyond 100 days of gestation as the fetus grows, making the uterus drop into the 
abdominal cavity and beyond the reach for proper orientation of the probe to the fetus (Curran, 
1992). Therefore, an alternative method that is more practical, less time-consuming, economical, 
and highly accurate in determining fetal sex in cattle would be desirable. 
One such potential method is PCR-based detection of the cffDNA in the maternal peripheral 
circulation. Initially, the cffDNA was reported to be present in low proportions (3.4-6.2%) in the 
blood samples of pregnant women (Dennis Lo et al., 1997). Subsequently, cffDNA has been used 
for non-invasive prenatal genetic screening of the fetus for sex determination (Dennis Lo, Tein, et 
al., 1998; Sekizawa, Kondo, et al., 2001) and heritable diseases (Bianchi, 2012; Ferrari et al., 2015; 
Mennuti et al., 2015; Skrzypek & Hui, 2017). A limited number of studies in domesticated and 
wild animals have reported prenatal fetal sex determination in horses (de Leon et al., 2012; 
Tonekaboni et al., 2020), elephants (Vincze et al., 2019), rhinoceros (Stoops et al., 2018), and 
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cattle with varying degrees of accuracy (Da Cruz et al., 2012; Ristanic et al., 2018). At least in 
humans, isolation of cffDNA from maternal blood for downstream testing has been observed to be 
affected by a variety of preanalytical factors such as sample collection method, type of sample, 
processing as well as storage of samples, and DNA extraction methods (Meddeb et al., 2019). Only 
one study in cattle has compared different DNA extraction methods (Ristanic et al., 2018), while 
none of the studies have analyzed the effect of plasma storage on the PCR-based prenatal sex 
determination.  
The overall aim of this study was to establish a protocol for PCR-based prenatal sex determination 
in cattle. Based on previous studies in humans (Meddeb et al., 2019) and cattle (Da Cruz et al., 
2012; G. Wang et al., 2010), we planned to use blood plasma samples over serum samples for this 
study. As the cost and turnaround time for PCR results could vary with different DNA extraction 
methods, we decided to compare various conventional, silica-based spin column and magnetic 
bead-based methods to extract cfDNA from the plasma of pregnant cattle. We hypothesized that 
plasma storage, DNA extraction methods, and target genes would differentially affect the PCR 
results for fetal sex determination. Our specific objectives were to a) determine the effect of stored 
plasma and freshly collected plasma on cffDNA extraction and downstream PCR for fetal sexing, 
and b) compare different DNA extraction methods on downstream PCR for fetal sexing in cattle. 
2.3. Materials and methods 
2.3.1. Animals 
The animal experimentation was conducted between October 2019 and October 2020 and was 
approved by the University of Saskatchewan Animal Care Committee (AUP#20190070). All 
animals (Canadian Holstein) included in the present experiment were located at Rayner Dairy 
Research and Teaching Facility, University of Saskatchewan. The dairy farm utilizes artificial 
insemination for breeding. The feeding, care, and management of the animals were done as per the 
routine for pregnant (mid-gestation and dry period). 
2.3.2. Experimental design 
A total of 34 pregnant cows (120-240 days), five heifers, and five bull calves (controls) were 
sampled during the experiment, which included four trials. Pregnancy diagnosis was routinely 
carried out within the dairy herd as part of bi-weekly herd health visits. During these visits, fetal 
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sexing via ultrasound was also carried out between 55-70 days of gestation and later confirmed 
with the determination of sex at birth.  
Trial 1: Using frozen plasma for PCR-based fetal sexing  
Blood samples were collected from pregnant cows (n=15, 120-150 days gestation) once weekly 
for 3 wks. The harvested plasma was stored at -200C until processed for cfDNA extraction and 
PCR. Further, blood samples from virgin heifers (n=5) and bull calves (n=5) were also collected 
to extract cellular DNA and stored in aliquots at -200C and used as controls in all trials (Figure 
2.1).  
Trial 2: Using fresh plasma for PCR-based fetal sexing  
In this trial, blood samples were collected from pregnant cows (n=6, 120-150 days gestation) only 
once, and freshly harvested plasma was processed for cfDNA extraction and PCR (Figure 2.1). 
Trial 3: Comparison of different DNA extraction methods 
In the last trial under this experiment, blood samples were taken from thirteen pregnant cows (150-
240 days pregnant). Depending upon the technique, the cfDNA was extracted on freshly harvested 
plasma or whole blood samples using three (Trial 3a, n=8) or seven different methods (Trial 3b, 
n=5) and then processed for PCR (Figure 2.1). 
2.3.3. Collection, processing, and storage of samples 
For all trials, duplicate peripheral blood samples were collected by caudal venipuncture from all 
animals using 6 ml K2 EDTA tubes (VWR Cat. No. CABD367863L; BD Vacutainer) and 
transported on ice to the Molecular Microbiology Research Laboratory, the University of 
Saskatchewan within 2 hours of blood collection. Samples from pregnant cows were processed to 
harvest plasma for all extraction protocols except for the Salting-out method (Trial 3b), which 
involves the use of a whole blood sample. In general, plasma was harvested by the two-step 
centrifugation method at 40C. In the first step, samples were centrifuged at 1600×g for 10 minutes 
(Stovall Legend RT Centrifuge, Cat. No. 40647502; Thermo Scientific), and during the next stage, 
the separated plasma was re-centrifuged at 16000×g for 10 mins (Eppendorf Centrifuge 5415R, 











stored at -200C, while fresh plasma samples were used for other Trials. Samples from heifers and 
bull calves were used to extract DNA from blood leukocytes during the Trial 1 and then aliquoted 
for later use. 
2.3.4. DNA extraction and quantification 
The DNA extraction methods used in different trials are listed below.  
Trial 1 (frozen plasma samples): During the initial phases of this experiment, DNA extraction from 
the frozen-thawed plasma samples of cows was performed using 100-1000 µl plasma using 
DNeasy Blood and Tissue Kit (Cat. No. 69506; Qiagen, Germany), 100-1000 µl plasma utilizing 
MagMAX cfDNA Isolation Kit (Cat. No. A29319; Applied Biosystems, USA), and 2 ml plasma 
using Phenol-chloroform method. Protocols provided by the manufacturer for both the commercial 
kits were modified to adjust for the volumes of plasma and the respective buffers. For DNeasy 
Blood and Tissue Kit, briefly, plasma was mixed with proteinase K and buffer AL. Following 
incubation at 56°C for 30 minutes, 100% ethanol was added, and samples were pipetted into the 
spin columns. After centrifugation for 1 minute, flow-through was discarded and two washings 
were performed using buffers AW1 and AW2. The DNA was eluted in 50 µl of elution buffer. For 
MagMAX cfDNA Isolation Kit, briefly, plasma was mixed with proteinase K and SDS. Following 
incubation at 60°C for 20 minutes, DNA lysis/binding solution and magnetic beads were added. 
After vigorous shaking for 10 minutes, one washing with the wash solution and two subsequent 
washings with 80% ethanol were performed. Lastly, DNA was eluted in 50 µl of elution buffer. 
For the phenol-chloroform-based DNA extraction, 2 ml of plasma was mixed with 50 µl of 20 
mg/ml proteinase K and 100 µl of 25% SDS. The mixture was then incubated at 56°C for 3 hours 
following the addition of ultrapure 2 ml 25:24:1 phenol:chloroform:isoamyl alcohol (Cat. No. 
77617; Sigma Aldrich, USA). The mixture was then vortexed for 30 seconds and centrifuged at 
3500×g for 15 minutes (Stovall Legend RT Centrifuge). The supernatant was transferred to a fresh 
tube and an equal volume of 24:1 chloroform:isoamyl alcohol (Cat No. 25666; Sigma Aldrich, 
USA) was added. The mixture was again vortexed for 30 seconds and centrifuged at 14000×g for 
10 minutes (Eppendorf Centrifuge 5415R). The supernatants were carefully transferred to clean 
1.5 µl microcentrifuge tubes (Cat. No. MCT-150-L-C; AXYGEN INC., Mexico) and 1/10 volume 
of 5 M NaCl and two volumes of 100% ethanol were added. The mixture was incubated at -20°C 
for half an hour and later centrifuged at 14000×g for 10 minutes. The supernatant was discarded 
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without disturbing the pellet and the precipitated DNA was then washed twice using 70% ethanol. 
The DNA pellet was then air-dried and deposited with 50 µl of TE buffer. The cellular DNA of 
blood samples from heifers and calves were extracted using DNeasy Blood & Tissue Kit as per 
the manufacturer’s protocol. 
Trial 2 (cfDNA extraction from fresh plasma): The cfDNA was extracted using the phenol-
chloroform method as described above.  
Trial 3 (comparison of extraction methods). During the first part of this trial (3a), cfDNA was 
extracted on the same day with DNeasy Blood and Tissue Kit, MagMAX cfDNA Isolation Kit, 
and phenol-chloroform method using 300 µl, 500 µl, and 2000 µl, respectively, for each of the 
freshly harvested plasma samples.  
Finally, Trial 3b involved DNA extractions using 300 µl plasma for DNeasy Blood & Tissue Kit, 
500 µl plasma for DSP Virus Kit (Cat. No. 60704; Qiagen, Germany), 2 ml plasma for DNA Blood 
Midi Kit (Cat. No. 51183; Qiagen, Germany), 2 ml plasma for NucleoMag cfDNA Isolation Kit 
(Cat. No. 744550.1; Macherey-Nagel, Germany), 500 µl plasma for MagMAX cfDNA Isolation 
Kit, and 100 µl plasma utilizing KAPA Express Extract Kit (Cat. No. KK7100; KAPA Biosystems, 
South Africa) as per the manufacturer’s protocols. For DSP Virus Kit, plasma was mixed with 
protease and lysis buffer. Following incubation at 56°C for 15 minutes, 100% ethanol was added, 
and the mixture was pipetted into MinElute column. Following centrifugation, two washings were 
performed with buffers AW1 and AW2. After this, another washing was performed with 100% 
ethanol and membrane of the spin column was air dried. The DNA was then eluted in 50 µl of 
elution buffer and immediately used as a template in the PCR. For DNA Blood Midi Kit, the 
extraction protocol was the same as previously described for DNeasy Blood & Tissue Kit. For 
NucleoMag cfDNA Isolation Kit, plasma samples were mixed with proteinase K and Buffer 
MCF1. Following incubation at 56°C for 30 minutes, magnetic beads and buffer MCF2 were 
added. After shaking the mixture for 10 minutes, one washing with buffer MCF3 and two washings 
with buffer MCF4 were performed. Lastly, magnetic beads were air dried, and DNA was eluted in 
50 µl of elution buffer. For KAPA Express Extract Kit, plasma was mixed with KAPA Express 
Extract Buffer and KAPA Express Extract Enzyme. The mixture was then incubated at 75°C for 
10 minutes (Lysis) followed by 95°C for 5 minutes (Enzyme activation). After this, centrifugation 
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was performed and 50 µl of the purified supernatant was collected, which contained the potential 
DNA. Additionally, whole blood samples from the same set of animals were used over plasma as 
per the salting-out protocol described in an earlier study (Lemos et al., 2011). Briefly, 450 μl of 
lysis buffer (sucrose 0.32 M, Tris–HCl 12 mM pH 7.5, MgCl2 5 mM, 1% Triton 100) was mixed 
with 1 ml of blood samples in an Eppendorf tube and centrifuged. Subsequently, the supernatant 
was discarded, and 1 ml of lysis buffer was added to the cellular debris and mixed. Again, 
centrifugation was performed, and this step was repeated 3-4 times until a clean pellet was 
obtained. The pellet was then resuspended in 80 μl of Proteinase K buffer (0.375 M NaCl; 0.12 M 
EDTA), and 280 μl of Milli-Q water, 10 μl of 20% SDS, and 8 μl of Proteinase K (25 mg/mL) 
were added to it. Samples were then incubated overnight (55°C). The following day, samples were 
kept at 4°C for 10 minutes, and then 120 μl of NaCl (5 M) was added to each sample, followed by 
centrifugation at 5000×g for 10 minutes (Eppendorf Centrifuge 5415R). The supernatant was 
transferred to clean Eppendorf tubes, 1 ml of absolute ethanol was added, and the samples were 
frozen at −85°C for 20 min. After removal from the freezer, samples were centrifuged again 
(10000×g for 10 minutes, Eppendorf Centrifuge 5415R), supernatants were discarded, and the 
pellets were washed in 70% ethanol. The pellets were allowed to air-dry, and the DNA was eluted 
in 50 μl of PCR grade water. 
DNA quantification: The amount of cfDNA extracted from all samples obtained for all trials was 
assessed using a Nanodrop spectrophotometer (Cat. No. ND-1000 UV-Vis; Thermo Fisher 
Scientific, USA). Further, the cfDNA extracted from samples collected under Trial 3a were 
processed using Invitrogen Qubit dsDNA BR Assay Kit (Cat. No. Q32850; Thermo Fisher 
Scientific, USA) as per the manufacturer's protocol and analyzed with Qubit 3.0 Fluorometer (Cat. 
No. Q33216; Thermo Fisher Scientific, USA). Additionally, representative samples (positive and 
negative for male fetus-specific PCR amplicons) from Trial 3a were assessed for DNA size 
distribution using Agilent 2100 bioanalyzer (Cat. No. G2939A; Agilent Technologies, USA). For 
this purpose, High sensitivity DNA chips (Cat. No. 5067-4626; Agilent Technologies, USA) were 
used. 
2.3.5. Polymerase chain reaction 
Three pairs of primers from previously published studies on PCR-based bovine fetal sex 
determination were selected (Table 2.1). In PCR, the bovine amelogenin (bAML) primer set 
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amplified a 467 bp sequence from X-chromosome and a 341 bp sequence from Y-chromosome. 
Thus, the amplification of both sequences in the PCR indicated a male fetus, whereas the 
amplification of only 467 bp sequence indicated a female fetus. The testis-specific protein Y 
(TSPY) primer set amplified a 260 bp sequence from Y-chromosome only. Therefore, its 
amplification in the PCR indicated a male fetus while its absence indicated a female fetus. 
Similarly, Y-specific sequence primer set amplified a 210 bp sequence from Y-chromosome only. 
The amplification of this sequence in the PCR indicated a male fetus, while its absence indicated 
a female fetus. A representative gel image following PCR with control DNA samples for each of 
these three genes is presented in Figure 2.2.  
The PCR reactions were performed in a 25 µl volume containing 1 µl (10 µM) of each forward 
and reverse primer, 0.5 µl (10 µM) dNTPs, 0.75 µl (37.5 mM) MgCl2, 2.5 µl 10x PCR buffer, 0.5 
µl of Platinum Taq DNA polymerase. To this, either 2.5, 5, or 10 µl of DNA extracts were added 
as a template in each PCR reaction as indicated in the results under different trials. More 
specifically, 2.5, 5, and 10 µl of template DNA volumes were used in Trials 1 and 2. In Trial 3a, 
2.5 and 10 µl of template DNA volumes were used. In Trial 3b, only 10 µl of template DNA 
volume was used. The remaining volume was compensated by adding PCR-grade water to the 
reaction mixture, making a final volume of 25 µl. However, 2 µl of the DNA extracts (from the 
blood cell fraction of control animals) were used as templates in the PCR controls, and the 
remaining volume (16.75 µl) was compensated by adding PCR-grade water to the reaction 
mixture, making a final volume of 25 µl. A non-template control (NTC) was included in every 
PCR batch to account for the cross-contamination of PCR tubes. 
The PCR was performed using Eppendorf Master Cycler (Model: Pro 6321; Cat. No. 
6321AK613475). The thermocycling protocol for Y-specific sequence PCR comprised of an initial 
DNA denaturation step at 94°C for 5 minutes followed by 40 cycles of DNA denaturation at 94°C 
for 60 seconds, primer annealing at 58°C for 30 seconds, extension at 72°C for 60 seconds, and a 
final extension step at 72°C for 7 minutes. On the other hand, the thermocycling protocol for 
bAML and TSPY PCR comprised of an initial denaturation step at 94°C for 5 minutes followed 
by 40 cycles of DNA denaturation at 94°C for 30 seconds, primer annealing (at 54°C for 30 
seconds for bAML; at 60°C for 30 seconds for TSPY), extension at 72°C for 30 seconds, and a 
final extension step at 72°C for 5 minutes. 
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Table 2.1: The pairs of three different primers used for PCR. 
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Figure 2.2: A representative image of gel electrophoresis following bAML, TSPY, and Y-specific 
gene PCR. Lane ‘B’ represents amplification of two gene sequences in bAML PCR (341 bp from 
Y-chromosome and 467 bp from X-chromosome), 260 bp gene sequence in TSPY PCR, and 210 
bp gene sequence in Y-specific PCR from the DNA isolated from the whole blood of a bull calf. 
Lane ‘C’ indicates amplification of a single 467 bp (X-chromosome) gene sequence in bAML PCR, 
no amplification in TSPY and Y-specific PCR when DNA isolated from the blood of heifer calf was 
used for PCR. Lane ‘L’ indicates a 100 bp DNA ladder while ‘NTC’ indicates non-template 
control. 
  
2.2a (bAML) 2.2b (TSPY) 2.2c (Y-specific) 
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2.3.6. Gel electrophoresis 
Following PCR, the amplicons were visualized on a 1% Ultrapure Agarose (Cat. No. 16500100; 
Invitrogen, USA) gel stained by 2 µl (20 µg) Ultrapure Ethidium Bromide (Cat. No. 15585011; 
Invitrogen, USA). The agarose gels containing Y-specific and TSPY PCR products were run at 
110 V for 30 minutes, whereas gels containing bAML PCR products were run at 110 V for 45 
minutes. Following electrophoresis, the gel images of the PCR products were captured using the 
ChemiDoc XRS+ system with Image lab software (Cat. No. 1708265; BIO-RAD, USA). 
2.3.7. DNA sequencing of the PCR products 
The PCR products that showed positive amplification of fetal sex chromosome-specific genes and 
PCR products of positive controls were subjected to Sanger sequencing to determine the nucleotide 
sequence of the amplified DNA. The 260 bp TSPY and 210 bp Y-specific PCR products were 
purified using QIAquick PCR Purification Kit (Cat. No. 28104; QIAGEN, Germany) as per the 
manufacturer’s protocol for this purpose. On the other hand, bAML double bands (341 and 467 
bp) were subjected to gel purification using QIAquick Gel Extraction Kit (Cat. No. 28706X4; 
QIAGEN, Germany) and prepared for the sequencing separately. The samples prepared for DNA 
sequencing were sent to Macrogen in Seoul, South Korea. The ABI file extensions received back 
from Macrogen were analyzed for quality using Pregap-4 and Gap-4 software (Staden package). 
After that, the DNA sequences were saved as FASTA files and were blasted in the NCBI database. 
2.3.8. Data handling and analyses 
The data generated from DNA quantification and PCR has been presented in a descriptive 
tabulated manner. No statistical comparisons were performed for the endpoints described in this 
chapter. 
2.4. Results 
2.4.1. cfDNA and cffDNA in frozen plasma (Trial 1) 
None of the frozen plasma samples from three replicates processed using three different DNA 
extraction methods yielded a positive result for either bAML or TSPY amplicons expected with 
the presence of cffDNA from a male fetus. Even after increasing the amount of plasma sample 
volumes (100 to1000 µl) or amount of extracted DNA used as PCR template (2.5, 5, and 10 µl), 
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results did not change (data not presented). All samples from all replicates using Blood and Tissue 
kit and MagMax cfDNA kits showed successful amplification of 467 bp bAML amplicons, 
indicating cfDNA of maternal origin. However, products representing maternal cfDNA could not 
be amplified following PCR in all samples processed with the phenol-chloroform method. 
2.4.2. cfDNA and cffDNA in fresh plasma (Trial 2) 
When DNA extracted from freshly processed plasma samples were used at different volumes (2.5, 
5, and 10 µl) as PCR templates in three separate reactions targeting both bAML and TSPY genes, 
none of the samples showed amplicons for TSPY gene. However, we observed 341 bp PCR 
products for the bAML gene sequence (consistent with cffDNA from a male fetus) in 4/6, 3/6, and 
5/6 samples when 2.5, 5.0, and 10 µl of DNA extracts were used as PCR templates, respectively 
(Figure 2.3). Moreover, 3/6, 2/6, and 5/6 samples showed 467 bp amplicons consistent with 
maternal cfDNA when 2.5, 5.0, and 10 µl of DNA extracts were used as PCR templates, 
respectively (Figure 2.3). 
2.4.3. Comparison of cfDNA extraction methods for fetal sex determination (Trials 3a 
and 3b) 
The amount of cfDNA extracted from different samples using different methods was observed to 
be either very low or below the detection limits of the Qubit fluorometer (Table 2.2).  
Table 2.2: Quantity of cfDNA detected in samples processed with different DNA extraction 
methods. 
Cow ID 
dsDNA concentration (ng/l) 





1 Too low Too low 0.285 
2 Too low Too low 0.260 
3 Too low Too low 0.157 
4 Too low Too low 0.257 
5 Too low Too low 0.067 
6 Too low Too low 0.395 
7 Too low Too low 0.257 
8 Too low Too low 0.466 
Qubit Fluorometer was used for DNA quantification. 
Following PCR using cfDNA extracted (with DNeasy Blood & Tissue Kit, phenol-chloroform 




Figure 2.3: bAML PCR results following phenol-chloroform based DNA extraction from freshly 
harvested plasma samples of six pregnant cows. The cows were 120-150 days pregnant and 
carrying male fetii. DNA extracted from 2 ml of plasma was eluted in 50 µl of TE buffer and PCR 
was carried out in triplicate using 2.5, 5, and 10 µl of template DNA. ‘L’: 100 bp DNA ladder; 
‘N’: Non-template control; ‘1-6’: presence/absence of 341 bp and/or 467 bp bAML gene 















10 µl of DNA templates in the PCR mix. However, 1/8 and 2/8 samples yielded positive TSPY 
amplification when 2.5 µl and 10 µl, respectively, of the DNA extracted by MagMAX cfDNA 
Isolation Kit were used as PCR templates (Table 2.3; Figure 2.4c). Further, one out of two samples 
that predicted a male fetus by TSPY PCR was identified as a false positive based on fetal sex 
determination by ultrasonography and fetal sex at birth (Table 2.3). Variations were also observed 
for bAML PCR between three extraction methods depending on the amount of PCR template used. 
None of the samples extracted by DNeasy Blood & Tissue and MagMAX cfDNA kits yielded 341 
bp bAML PCR product when 2.5µl template was used (Figures 2.4a and 2.4b), while 2/8 samples 
processed with phenol-chloroform method showed the presence of male fetal-specific 341 bp 
amplicon. On the other hand, 3/8 (Figure 2.4a), 3/8 (Figure 2.4b), and 1/8 samples resulted in a 
bAML PCR product (341 bp), indicating the presence of a male fetus with 10 µl of template 
obtained by DNeasy Blood & Tissue kit, MagMAX cfDNA kit, and phenol-chloroform method, 
respectively. Additionally, one positive 341 bp amplification in each of the PCR batches from the 
DNA extracts of three DNA extraction methods was found to be false positives as female calves 
were born to those dams (Table 2.3). 
Further, the Agilent High Sensitivity DNA assay for size distribution analyses on representative 
DNA samples obtained from all three DNA extraction methods (that showed successful 
amplification in bAML and/or TSPY gene PCR) was unsuccessful (Figure 2.5). These 
observations again indicated that the cfDNA concentration in the plasma DNA extracts might be 
too low and could be beyond the detection limits of these techniques despite the successful PCR 
amplification. In contrast, only one DNA extract from the phenol-chloroform method (PC-8 in 
Figure 2.5) showed a little 980 bp peak with only 3.8 pg/µl DNA concentration; however, the DNA 
template from this extract failed to amplify in the PCR (phenol-chloroform extract from cow ID-








Table 2.3: PCR (bAML) results for fresh plasma samples from cows (n=8, 150-240 days pregnant) 












Fetal sex at 
birth 
1 
341 bp + - - 
F 
467 bp - + - 
Predicted Sex M F - 
2 
341 bp + + + 
M 
467 bp + + - 
Predicted Sex M M M 
3# 
341 bp - + + 
F 
467 bp + + + 
Predicted Sex F M M 
4 
341 bp + - - 
M 
467 bp + + - 
Predicted Sex M F - 
5 
341 bp - - - 
M 
467 bp + + + 
Predicted Sex F F F 
6 
341 bp - + - 
M 
467 bp + + + 
Predicted Sex F M F 
7 
341 bp - - - 
F 
467 bp + + + 
Predicted Sex F F F 
8# 
341 bp - - - 
M 
467 bp - + - 
Predicted Sex - F - 
‘#’ indicates successful amplification of 260 bp TSPY amplicon in the respective DNA extract of 
MagMAX cfDNA Isolation Kit. 
‘F’ and ‘M’ indicate female and male fetal sex, respectively. 




                    
                     
                     
Figure 2.4: bAML (DNeasy Blood & Tissue Kit; MagMAX cfDNA Isolation Kit) and TSPY 
(MagMAX cfDNA Isolation Kit) PCR results following DNA extraction from freshly harvested 
plasma samples of eight pregnant cows. The cows were more 150-240 days pregnant (5 carrying 
male fetii, 3 carrying female fetii as indicated in Table 2.3). Following extraction, DNA was eluted 
in 50 µl of elution buffer and both bAML and TSPY PCR were carried out in duplicate using 2.5 
and 10 µl of template DNA volume. ‘L’: 100 bp DNA ladder; ‘NT’: Non-template control; ‘1-8’: 
presence/absence of 341 bp and/or 467 bp bAML as well as 260 bp TSPY gene sequences in the 
DNA samples from pregnant cows; ‘B’ and ‘C’ indicate bull and heifer PCR controls, respectively. 
 
2.4a (bAML; DNeasy Blood & Tissue Kit 
2.4b (bAML; MagMAX cfDNA Isolation Kit 




Figure 2.5: Agilent High Sensitivity DNA assay depicting the size range of DNA in the plasma 
DNA extracts of three DNA extraction methods. The X-axis indicates the length of DNA fragments 
in base pairs (bp) with a 35 bp peak indicating ‘low DNA marker’ and 10380 bp peak indicating 
‘high DNA marker’. The Y-axis indicates the fluorescence units (FU). MM: MagMAX cfDNA 
Isolation Kit; PC: Phenol-chloroform method; BT: DNeasy Blood & Tissue Kit.   
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The results of PCR (bAML and Y-specific) for 10 µl of cfDNA template obtained using seven 
different methods are shown in Table 2.4. Among the spin-column-based DNA extraction 
techniques, the PCR on DNA isolated from fresh maternal plasma using the DNeasy Blood & 
Tissue and QIAamp DSP Virus kits correctly predicted the presence of male fetii in 2/5 and 3/5 
cows (Figures 2.6a and 2.6b), respectively. On the other hand, PCR on the cfDNA obtained from 
QIAamp DNA Midi Kit (Figures 2.6a and 2.6b) and single tube extraction kit (KAPA express 
extract kit) failed to predict the presence of male fetii in all five cows. Furthermore, PCR on the 
DNA isolated using magnetic beads-based techniques (NucleoMag cfDNA Isolation and 
MagMAX cfDNA Isolation kits) correctly predicted the presence of male fetii in 2/5 cows each. 
The PCR on DNA obtained from the Salting out protocol correctly predicted the presence of male 
fetii in 2/5 cows. However, the PCR lanes showed smearing on the agarose gel (data not shown).  
2.4.4. DNA sequencing results 
Sequencing results of the PCR products of 341 bp bAML amplicons from both bull controls and 
test samples showed that the amplified products were part of the Amelogenin-Y gene of Bos 
taurus, showing 94-100% similarity to the bovine bAML gene sequence. Similarly, 467 bp bAML 
amplicons were found to be part of the Amelogenin-X gene of Bos taurus showing 96-100% 
similarity to the actual gene sequence. Furthermore, sequencing results of 260 bp TSPY amplicons 
from both bull controls and test samples showed that the products amplified in the PCR were part 
of the Testes specific protein-Y gene of Bos taurus, showing 93-100% similarity to the true gene 
sequence. Likewise, 210 bp Y-specific sequence PCR products from both bull controls and test 
samples were found to be the part of Bos taurus Y-chromosome showing 90-100% similarity to 
the actual gene sequence. 
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341 bp bAML - - - - - - - 
467 bp bAML + - + + + + + 
210 bp Y-specific - + - + - - + 
2 
341 bp bAML + - - - + - - 
467 bp bAML + + + + + + + 
210 bp Y-specific - + - + - - - 
3 
341 bp bAML - + - - + - - 
467 bp bAML + + + + + + + 
210 bp Y-specific - - - - - - - 
4 
341 bp bAML - - - - - - - 
467 bp bAML + + + + + + + 
210 bp Y-specific + - - - - - + 
5 
341 bp bAML - - - - - - - 
467 bp bAML + + + + + - + 
210 bp Y-specific - - - - - - - 
Correct prediction of male 
fetii 
2 3 0 2 2 0 2 








            
 
 
            
 
Figure 2.6: bAML and Y-specific PCR results following DNA extraction from freshly harvested 
plasma samples of five pregnant cows utilizing QIAamp DNA Midi Kit and QIAamp DSP Virus 
Kit. The cows were 150-240 days pregnant and carrying male fetii. Following extraction, DNA 
was eluted in 50 µl of elution buffer and both bAML and Y-specific PCR were carried out 
separately using 10 µl of template DNA. ‘L’: 100 bp DNA ladder; ‘N’: Non-template control; ‘E’: 
Extraction control; ‘1-5’: presence/absence of 341 bp and/or 467 bp bAML as well as 210 bp Y-
specific gene sequences in the DNA samples from pregnant cows; ‘B’ and ‘C’ indicate bull and 
heifer PCR controls, respectively). 
2.6a (bAML; QIAamp DNA Midi Kit, QIAamp DSP Virus Kit 




The present study provided initial information on developing a PCR test targeting the sex-
chromosome-specific genes for use in prenatal fetal sex determination in pregnant cows. We 
determined that the fresh plasma would be better than frozen plasma samples to extract cfDNA 
and carry out PCR for fetal sexing. Further, we identified Y-specific and bAML genes to be better 
PCR targets for fetal sex determination. Additionally, we observed variability in the PCR results 
between animals and also due to different DNA extraction methods.  
Previous studies in cattle have either utilized the frozen (Davoudi et al., 2011; G. Wang et al., 
2010) or fresh plasma (Da Cruz et al., 2012) and reportedly achieved successful amplification of 
PCR products specific to the presence of male fetii in the pregnant cows. Interestingly, none of the 
frozen samples (of three replicates) processed for DNA extraction with different methods in the 
current study yielded PCR products specific to the male fetus even though the pregnant cows were 
carrying a male fetus. Earlier studies had shown that freeze-thaw cycles before DNA extraction 
could cause DNA fragmentation and compromise the integrity of cfDNA (K. A. Chan et al., 2005; 
El Messaoudi et al., 2013). This might have been the case in the present study with the frozen 
samples because the cfDNA has been observed to undergo rapid degradation (Zandvakili & 
Lazaridis, 2019). On the other hand, the lack of amplicons expected for maternal cfDNA for frozen 
samples processed with the phenol-chloroform method could be attributed to increased steps and 
carryover of PCR inhibitors such as large amounts of salts, proteins, and phenol in the isolated 
DNA samples (Lemarchand et al., 2005; Nolan et al., 2006). On the contrary, PCR on some of the 
fresh plasma samples did show expected amplicons consistent with the presence of a male fetus 
when different extraction methods were used. Overall, our observations using fresh plasma from 
the pregnant cattle for PCR to ascertain the fetal sex were different from previous reports that 
showed higher accuracy, sensitivity, and specificity for cattle >60 days pregnant (Da Cruz et al., 
2012). Since the cfDNA in human circulation is highly degraded due to nuclease activity (Sanchez 
et al., 2018), AACC recommends that plasma harvested from blood must immediately be cooled 
to refrigeration temperature, and if cfDNA extraction has to be further delayed, it must be stored 
between -20 to -80°C to minimize ex-vivo nuclease activity (Meddeb et al., 2019). In our case, 
even when fresh plasma samples were used for DNA extraction with different methods, the 
accuracy of fetal sexing was lesser. This might be because of the variability of cfDNA 
concentrations between subjects as reported in humans (Wright & Burton, 2009), although no such 
61 
 
study has been carried out in cattle. Another explanation could be the variable efficacies of 
different DNA extraction methods to isolate cffDNA from maternal plasma or blood as reported 
in cattle (Davoudi et al., 2011; Ristanic et al., 2018). To date, no study has compared the fresh and 
frozen plasma for DNA extraction and PCR for fetal sexing in cows. We used both fresh and frozen 
plasma samples from pregnant cows in different experimental trials to determine the appropriate 
sample type for fetal DNA extraction. After ascertaining that fresh plasma was better than frozen, 
we performed DNA extraction utilizing fresh plasma samples from pregnant cows (using several 
DNA extraction methods) following PCR targeting bAML and TSPY/Y-specific genes.  
In our trial comparing three different DNA extraction methods with fresh plasma samples from 
pregnant cows, we found that only a couple of DNA extracts obtained by the MagMAX cfDNA 
Isolation kit yielded amplicons specific to TSPY in the PCR while all the other samples came out 
TSPY negative. Although male fetal bAML amplicons in the PCR were detected in several DNA 
extracts obtained by all three methods, lack of amplification in TSPY PCR could be because of 
the lower sensitivity of these primers compared to bAML primers as different primers have been 
found to show variable sensitivities in detecting a particular target (Marcon et al., 2011). Another 
explanation could be the variability of various DNA extraction methods in extracting the fetal 
DNA fragments from the plasma of pregnant cows (Davoudi et al., 2011; Ristanic et al., 2018). 
Our findings are contrary to earlier studies that have reported consistent amplification of male fetal 
DNA in the PCR targeting the TSPY gene using the same set of primers (Davoudi et al., 2011; 
Lemos et al., 2011). 
Within the limitations of a smaller number of samples included in our trials comparing three and 
seven different DNA extraction methods periodically, we observed wide variations in the PCR 
results for bAML and TSPY/Y-specific genes, which are similar to some reports in cattle (Davoudi 
et al., 2012; Ristanic et al., 2018). Since the proportion of cffDNA is extremely low in maternal 
circulation (3.4-6.2%) as reported in women (Dennis Lo, Tein, et al., 1998), larger yields of 
maternal cfDNA inhibit the retention of shorter fetal DNA sequences during extraction (Suzuki et 
al., 2008). Furthermore, it has been reported that the proportion of cfDNA is the only factor that 
determines the success of cfDNA based diagnostic assays (Canick et al., 2013). Therefore the 
extremely low fetal fraction in maternal blood of pregnant women is the chief culprit of negative 
assay results (Lench et al., 2013). This might be true in our case because the DNA extracts had 
extremely low DNA concentrations that were beyond the Qubit fluorometer's detection limits. The 
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failure of amplification of male fetus-specific sequences in bAML and TSPY/Y-specific PCR 
might be attributed to the fact that the quality and quantity of DNA templates can significantly 
impact the accuracy, sensitivity, and reliability of the PCR-based methods (Nolan et al., 2006). 
Moreover, we observed a variation in the comparative efficacy of different extraction 
methodologies in isolating cffDNA from the maternal plasma, which is congruent to other studies 
carried out in humans (Akbariqomi et al., 2019) and cows (Davoudi et al., 2011; Ristanic et al., 
2018). Differences in methodologies and underlying extraction principles for each kit might 
determine the extent of retention of highly fragmented fetal DNA sequences (Cicchillitti et al., 
2017; Fleischhacker & Schmidt, 2007). On the other hand, some studies have indicated consistent 
and highly accurate results of PCR-based prenatal sexing of the fetus in cattle (Lemos et al., 2011; 
G. Wang et al., 2010). 
Although we had a limited sample size, overall, different kits yielded wide variations in PCR 
results. Contrary to the previous report on the single tube KAPA Express Extract Kit to be better 
than both spin-column and manual in-house DNA extraction methods (Ristanic et al., 2018), we 
did not amplify any male fetus-specific sequence in the samples from all cows. Similarly, we had 
lower success (2/5 samples) with the salting-out protocol than a previous study that used the same 
extraction method and reported a 100% accuracy for TSPY PCR in pregnant cattle (Lemos et al., 
2011). The use of whole blood might have released maternal DNA that caused the background 
smearing in the gel images in the present study.  
2.6. Conclusions 
In conclusion, the freshly harvested but not frozen-thawed plasma from pregnant cattle could be 
used for PCR-based prenatal fetal sexing. The fresh plasma samples from pregnant cows were 
found to be better than the frozen-thawed plasma samples in terms of their relative amplification 
of fetal DNA in the PCR. Although the fetal gene sequences were successfully amplified in some 
samples when DNA extracts from three different DNA extraction methodologies were subjected 
to PCR, the size distribution of these extracted cfDNA samples could not be ascertained using 
Agilent High Sensitivity Bioanalyzer owing to the extremely low yields of cfDNA as reported by 
Qubit Fluorometer. Furthermore, when compared, seven different DNA extraction methods were 
found to yield variable results in their ability to isolate fetal DNA from the plasma of pregnant 
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cows. Therefore, the current PCR methodology for fetal sexing in pregnant cattle is unreliable for 
field applications as the obtained results were no better than chance predictions. 
2.7. Transition 
The relative variation in the extraction efficiency of different DNA extraction methodologies could 
be because of the extremely low and variable concentrations of fetal DNA in the plasma of 
pregnant cows. So, chapter 3 was focused on a series of spiking experiments aimed to determine 





3. DETERMINATION OF THE LOWER LIMITS OF CELL-FREE FETAL DNA IN 
BOVINE PLASMA SAMPLES FOR PCR DETECTION 
3.1. Abstract 
Objectives: The specific objectives of this study were to a) determine if spiked fetal DNA could 
be recovered from maternal plasma, b) ascertain the minimum concentrations of cffDNA that can 
be extracted from maternal plasma and amplified with PCR to identify bAML and Y-specific 
amplicons, c) compare the PCR results of samples taken from cows at different stages of gestation 
and d) compare three different commercial kits for extraction of cffDNA from spiked and neat 
plasma samples of pregnant cows.  
Materials and methods: In the Trial 4, serum and cellular DNA from five aborted male fetii were 
spiked in the plasma of their respective dams at different proportions, followed by re-extraction 
and PCR. In the Trial 5, male fetal cellular DNA at different dilutions was spiked in the plasma of 
unrelated pregnant cows (n=10, 120-150 days pregnant, each carrying a male fetus) and non-
pregnant heifers (n=10) followed by re-extraction and PCR. We used spiked (with 35 pg/ml male 
fetal DNA) and neat plasma samples from pregnant cows carrying male fetii (n=9, 60-150 days 
pregnant versus n=10, 151-240 days pregnant) in the Trial 6 for DNA extraction and PCR. In the 
Trial 7, spiked (with 35 pg/ml male fetal DNA) and neat plasma samples from pregnant cows (n=5, 
181-240 days, carrying a male fetus) were used for DNA extraction using three different kits and 
followed by PCR. Fisher’s exact test was used to compare the proportion of samples from two 
gestational groups with the correct prediction of fetal sex using PCR. 
Results: In the Trial 4, all maternal plasma samples spiked with either the fetal serum or fetal 
cellular DNA at all dilution rates (0.5-100%) showed amplicons following Y-specific PCR. In the 
Trial 5, male fetus-specific amplicons were detected in the maternal plasma spiked with >31.25 
pg/ml and >2ng/ml male fetal DNA for Y-specific PCR and bAML PCR, respectively. In the Trial 
6, the proportion of cows with a positive PCR in the 60-150 days gestation group were lower 
(P<0.05) than the 151-240 days group (3/9 versus 9/10, respectively). In the Trial 7, spiked fetal 
DNA was recovered in all the samples processed with three kits; however, only 3/5 (Blood & 
Tissue Kit), 1/5 (DSP Virus Kit), and 0/5 (NucleoMag Kit) neat plasma samples yielded male fetal 
sequences in the Y-specific PCR. 
65 
 
Conclusions: Y-specific primers were more sensitive than bAML primers in amplifying lower 
limits of cffDNA in maternal plasma (i.e., 31.25 pg/ml). In addition, the sensitivity of fetal sexing 
using Y-specific PCR was higher during the second-half of the gestation but the finding needs to 
be further tested on a large number of samples. 
3.2. Introduction 
Following the discovery of cffDNA in the maternal blood circulation of pregnant women (Dennis 
Lo et al., 1997), research work over the next three decades determined that individual variations 
(Wright & Burton, 2009), stage of gestation (Dar et al., 2016), and laboratory factors (El 
Messaoudi et al., 2013; Meddeb et al., 2019) could affect the extraction of cffDNA. These efforts 
lead to the development of non-invasive prenatal testing of the unborn baby for sex-chromosome-
related defects (Yao et al., 2014) and genetic disorders (Drury et al., 2016) besides fetal sexing 
(Kazachkova et al., 2019). Despite the presence of additional tissue layers of the interhemal 
membrane in ruminants compared to humans, the synepitheliochorial placenta in cattle might 
allow the passage of minute quantities of cffDNA in the maternal circulation of pregnant cows (P. 
Wooding & Burton, 2008). As a result, various studies have periodically focused on bovine 
prenatal fetal sex determination utilizing circulating cffDNA in maternal peripheral blood and have 
reported varying degrees of accuracy (Da Cruz et al., 2012; Davoudi et al., 2011; Kadokawa et al., 
1996; Lemos et al., 2011; Ristanic et al., 2018; Turin et al., 2007; G. Wang et al., 2010). While the 
initial study demonstrated the absence of bovine fetal cells and cffDNA in the blood circulation of 
pregnant cows (Kadokawa et al., 1996), subsequent studies showed that fetal sex chromosome-
specific genes could be targeted using PCR to determine fetal sex in pregnant cows (Da Cruz et 
al., 2012; Davoudi et al., 2011; Lemos et al., 2011; Ristanic et al., 2018; G. Wang et al., 2010). 
Our first experiment exhibited limited success and wide variability in prenatal determination of 
fetal sex using PCR. In pregnant mares, which have epitheliochorial placenta, the accuracy of 
PCR-based fetal sex determination was observed to be 48.7% and 68.7% in first and second-
trimester pregnant mares, respectively (Tonekaboni et al., 2020). It has been proposed that fetal 
genetic material might transfer across the placenta in pregnant cattle, which could occur transiently 
but predominantly during parturition (Turin et al., 2007). In such a situation, the PCR results for 
fetal sexing would vary between cows at a similar stage of gestation and repeat samples from the 
same cows would yield different outcomes.  
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Variability in the PCR-based fetal sex determination assays in the case of pregnant cows and other 
domestic animals might also occur due to lower amounts of cffDNA in the maternal plasma. 
Studies in humans have indicated that the absence or meager amounts of cffDNA is likely the 
leading cause of negative assay results (Lench et al., 2013). Furthermore, these low quantities of 
cffDNA molecules are overshadowed by the presence of a relatively large number of maternal 
cfDNA molecules (Wright & Burton, 2009). Therefore, a fetal fraction of at least 4% is 
recommended for adequate assay results in the case of humans (Grace et al., 2016), but no such 
information for cattle exists in the literature.  
We hypothesized that cffDNA might be low and variable in the plasma of pregnant cows, making 
it challenging to extract for conventional PCR. Therefore, our main objective was to determine 
minimum concentrations of cffDNA that can be re-extracted from maternal plasma to use for PCR. 
Specifically, we wanted to test the lowest limits of spiked cffDNA that can be re-extracted and 
amplified with PCR to identify bAML and Y-specific amplicons. Our secondary objectives were 
to a) determine the efficacy of the PCR-based prenatal sexing in cattle at different stages of 
gestation and b) compare three different commercial kits for extraction of cffDNA from spiked 
and neat plasma samples of pregnant cows. 
3.3. Materials and methods 
3.3.1. Animals and their management 
In the present study, 15 non-pregnant dairy heifers (Canadian Holstein), 34 pregnant dairy cows 
(Canadian Holstein), and 20 pregnant beef cows (Angus) were included. Dairy cows were located 
at the Rayner Dairy Research and Teaching Facility and managed as mentioned in chapter 2. Beef 
cows were from the Livestock Centre for Forage Research and Excellence, University of 
Saskatchewan, and were 60-150 days pregnant following natural breeding with a bull. The beef 
cows were being aborted as part of a parallel metabolic study. Furthermore, five each of the virgin 
heifers and bull calves (Rayner Dairy Research and Teaching Facility, University of 
Saskatchewan) were also included in the study, and the blood samples collected from them were 
used for DNA extraction that served as controls in all the PCR batches. The study was approved 
by the University of Saskatchewan under the AUP# 20190070. 
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3.3.2. Sample collection from aborting cows and their aborted fetii 
The abortions were induced in pregnant beef cows using 500 µg Cloprostenol sodium 
(Estrumate®, MSD) and 25 mg Dexamethasone sodium phosphate (Dexamethasone 5®, 
Vetoquinol). Cows were then observed at eight hours intervals for the expulsion of an aborted 
fetus. Based on vaginal discharge, rectal palpation, and stage of gestation at the induction of 
abortion, 17/20 aborted fetii were identified with the corresponding mothers. The aborted fetii 
were placed in a portable cooler and transported to the Westgen Research Suite, University of 
Saskatchewan. The sex of the aborted fetus was confirmed based on the examination of the external 
genitalia. Out of 17 aborted fetii, nine were identified to be male, and blood was successfully 
collected by cardiac puncture from 5/9 male fetii using 10 ml serum separator tubes (VWR Cat. 
No. CABD366430; BD Vacutainer). Within 24 h of abortion, duplicate blood samples were 
collected from the respective mothers of aborted fetii by coccygeal venipuncture in 6 ml K2 EDTA 
tubes (VWR Cat. No. CABD367863L; BD Vacutainer). All collected samples from the cows and 
aborted fetii were immediately transported on ice to the Molecular Microbiology Research 
Laboratory for further processing. 
3.3.3. Collection of blood samples from non-pregnant heifers and unrelated pregnant 
cows 
Peripheral blood samples from the caudal vein were collected from 15 non-pregnant Holstein 
Friesian heifers and 34 pregnant Holstein Friesian cows (carrying male fetii, as described earlier) 
grouped in different gestational stages at varying points in time. The blood samples were collected 
in duplicate from each heifer/cow in 6 ml K2 EDTA tubes (BD Vacutainer). The collected blood 
samples were placed in the icebox and carefully transported to the Molecular Microbiology 
Research Laboratory, the University of Saskatchewan, within two hours of blood collection. The 
blood samples were immediately processed for harvesting plasma. 
3.3.4. Processing of blood samples 
All the blood samples collected from aborted fetii and their dams, non-pregnant heifers, and 
pregnant dairy cows were immediately processed for separation of serum/plasma as explained 
previously (subsection 2.3.3). Fresh plasma, serum, and fetal blood cell fractions were immediately 
used for DNA extraction. 
68 
 
3.3.5. Experimental design 
The current experiment included the following series of trials to fulfill the study objectives. 
Trial 4: Spiking of maternal plasma from aborting cows with fetal serum and DNA 
This experiment was aimed to determine the possibility of re-extraction of fetal serum/DNA spiked 
into the plasma of their respective mother at different proportions of v/v dilutions. For this, freshly 
harvested fetal serum and DNA extracted from fetal blood cell fraction from five aborted male 
fetii were spiked into the plasma of their respective dams in two separate experiments, as described 
in Table 3.1 and Figure 3.1. The final 300 µl volume of neat or spiked maternal plasma was used 
for DNA extraction and downstream PCR targeting Y-specific gene.  








Total volume (l) 
% of fetal serum/fetal cellular DNA in 
maternal plasma (v/v) 
300 0 300 0 
298.5 1.5 300 0.5 
285 15 300 5 
262.5 37.5 300 12.5 
225 75 300 25 
150 150 300 50 
0 300 300 100 
Trial 5: Spiking of plasma from non-pregnant heifers and pregnant dairy cows with fetal DNA  
Trial 5a: To determine the lower range of cffDNA concentrations needed for successful re-
extraction and PCR, we spiked male fetal DNA in the plasma of randomly assigned non-pregnant 
heifers (n=5) and pregnant unrelated dairy cows (n=5, 120-150 days pregnant; carrying male fetii) 
as mentioned in Table 3.2. Based on the known amounts of fetal DNA (quantified by Qubit) at the 
initial dilution step, the estimated amount of cffDNA at subsequent dilutions is shown in Table 
3.2. The final 300 µl volume of neat or spiked maternal plasma was used for DNA extraction and 





Figure 3.1: Trial 4 experimental design.
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Table 3.2: Serial dilution rate of fetal DNA in the plasma of unrelated non-pregnant heifers (H1-H5) and pregnant cows (C1-C5: 120-





Volume of fetal 








used for DNA 
extraction 
Known (5% v/v) and expected amounts (subsequent serial 
dilutions) of fetal DNA in 300 µl heifer/cow plasma (n=5 
each) used for re-extraction of DNA 
H1/C1 H2/C2 H3/C3 H4/C4 H5/C5 
5 N/A 20 µl (neat) 380 µl 300 556.5 ng 2505 ng 304.5 ng 250.5 ng 525 ng 
2.5×10-1 2x10-1 20 µl (5%) 380 µl 300 27.82 ng 125.2 ng 15.22 ng 12.52 ng 26.25 ng 
1.25×10-2 2x10-2 20 µl (20-1) 380 µl 300 1.39 ng 6.26 ng 761 pg 626 pg 1.31 ng 
6.25×10-4 2x10-3 20 µl (20-2) 380 µl 300 69.5 pg 313 pg 38.05 pg 31.3 pg 65.5 pg 
3.12×10-5 2x10-4 20 µl (20-3) 380 µl 300 3.47 pg 15.65 pg 1.9 pg 1.56 pg 3.27 pg 
1.56×10-6 2x10-5 20 µl (20-4) 380 µl 300 173.5 fg 782.5 fg 95 fg 78 fg 163.5 fg 
7.80×10-8 2x10-6 20 µl (20-5) 380 µl 300 8.67 fg 39.12 fg 4.75 fg 3.9 fg 8.17 fg 
3.91×10-9 2x10-7 20 µl (20-6) 380 µl 300 433.5 ag 1.96 fg 237.5 ag 195 ag 408.5 ag 







Trial 5b: To further determine the lowest concentration of fetal DNA needed for a successful re-
extraction, a known amount of fetal DNA (2 ng) was spiked in 1000 µl plasma from a separate set 
of unrelated five non-pregnant heifers and five pregnant cows (120-150 days pregnant; carrying 
male fetii). Further dilutions were made for each set of spiked plasma so that progressive dilutions 
had a gradually halving fetal DNA concentration/ml of maternal plasma (Figure 3.2). The DNA 
re-extraction was performed from all the dilutions of each replicate and PCR was performed to 
amplify both Y-specific and bAML gene sequences. In addition, 300 µl of non-spiked (neat) 
plasma samples of each heifer/cow were also simultaneously used for DNA extraction and PCR 
(Figure 3.2).  
Trial 6: Assessing the effect of gestation stages at sampling on prenatal fetal sexing using PCR 
Using the minimum re-extractable concentration of fetal DNA identified in Trial 5b as our positive 
control, we compared the two gestational stages of pregnant cows for prenatal fetal sexing using 
PCR. For this trial, male fetal DNA was spiked at the lowest re-extractable concentrations in the 
plasma from a separate set of non-pregnant heifers (n=5), pregnant cows carrying male fetii (n=9 
cows 60-150 days pregnant; n=10 cows 151-240 days pregnant carrying male fetus). The DNA 
extraction and PCR for Y-specific sequence were carried out on spiked and neat plasma samples 
of nineteen pregnant cows and five non-pregnant heifers (Figure 3.3).  
Trial 7: Assessing the effect of the DNA extraction method on prenatal fetal sexing using PCR  
In this trial, a separate set of pregnant cows (n=5, 181-240 days gestation carrying male fetus) 
were selected for blood collection. The neat plasma samples and plasma samples spiked with the 
lowest re-extractable concentration of male fetal DNA were used for DNA extraction using three 
different kits and downstream PCR for Y-specific sequence (Figure 3.4).  
3.3.6. DNA extraction and quantification 
The fetal blood cell fraction (10 µl) and plasma samples (300 µl, non-spiked and spiked) from 
Trials 4, 5, and 6 were processed for DNA extraction using the DNeasy Blood & Tissue Kit 
(Qiagen). Whereas, for trial 7, DNeasy Blood & Tissue (Qiagen), QIAamp DSP Virus (Qiagen), 
and NucleoMag cfDNA Isolation (Macherey-Nagel) kits were used for DNA extraction from each 




















these kits in subsection 2.3.4. The extracted DNA from fetal blood cell fraction and blood cells of 
positive control animals was eluted in 200 µl of elution buffer and stored at -20°C until further 
use. The DNA extracted from spiked and neat plasma samples of heifers/pregnant cows was eluted 
in 50 µl (Trials 4, 5b, 6, and 7) and 80 µl (Trial 5a) elution buffer and was immediately used for 
PCR.  
DNA quantification: The DNA extracted from the blood cell fraction of aborted male fetii was 
quantified using Qubit 3.0 Fluorometer (Thermo Fisher Scientific), as explained previously under 
subsection 2.3.4. 
3.3.7. PCR and gel electrophoresis 
Based on previous studies and the observations made in our research (chapter 2), primer pairs 
targeting Y-specific sequences and bAML gene (Table 2.1) were used. For all PCR reactions, 10 
µl of DNA extract (non-spiked and spiked samples) was used, while other contents of the PCR 
mixture were similar to our previous study (subsection 2.3.5).  However, 2 µl of the DNA extracts 
(from the blood cell fraction of control animals) were used as templates in the PCR controls. The 
remainder of the volume (16.75 µl) was compensated by adding PCR-grade water to the reaction 
mixture, making a final volume of 25 µl. A non-template control was included in every PCR batch 
to account for the cross-contamination of PCR tubes. The thermocycling protocols for Y-specific 
and bAML PCR were used as described earlier (subsection 2.3.5). For gel electrophoresis, the 
protocol for separating amplicons based on size was carried out as explained in subsection 2.3.6. 
3.3.8. Statistical analysis 
The proportions of correct prediction of fetal sex between two groups of pregnant cows using PCR 
(Trial 6) were compared by Fisher’s exact test using SPSS 28.0 (SPSS for windows by 
International Business Machines). P-value <0.05 was considered statistically significant. 
3.4. Results 
3.4.1. Re-extraction of fetal serum and DNA spiked into plasma samples of their 
respective dams (Trial 4) 
We observed that spiking of mother’s plasma with fetal serum samples (Table 3.3; Figure 3.5a) or 
fetal DNA from cell fractions (Table 3.4; Figure 3.5b) of a male fetus at all dilution rates resulted 
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in amplification of Y-specific amplicon. No PCR product was observed in the neat plasma of cows 
induced to abort and non-template control, whereas appropriate amplification in positive controls 
indicated successful PCR.  
Table 3.3: PCR results of male fetal serum spiked at different concentrations (v/v) in the maternal 
plasma. 
% of fetal serum in 
maternal plasma (v/v) 
Y-specific PCR result 
(n=5) 
1 2 3 4 5 
0 - - - - - 
0.5 + + + + + 
5 + + + + + 
12.5 + + + + + 
25 + + + + + 
50 + + + + + 
100 + + + + + 
‘+’ and ‘–’ indicate the presence and absence, respectively, of gene amplicon (210 bp) in PCR. 
Table 3.4: PCR results of male fetal cellular DNA spiked at different concentrations (v/v) in the 
maternal plasma. 









1 2 3 4 5 
0 0 0 0 0 0 - 
0.5 24.9 34.8 7.9 2.2 5 + 
5 249 348 79 22 50 + 
12.5 622.5 870 197.6 55.8 124.9 + 
25 1245 1740 395.2 111.7 249.7 + 
50 2490 3480 790.5 223.5 499.5 + 
100 4980 6960 1581 447 999 + 




                   
 
                   
 
Figure 3.5: Y-specific PCR results following DNA extraction from the plasma samples (spiked 
with the fetal serum/fetal cellular DNA from their respective aborted male fetii) of aborted beef 
cows. Spiking of fetal serum/fetal cellular DNA in the maternal plasma was performed at different 
levels of v/v dilutions viz. 0% (A), 0.5% (B), 5% (C), 12.5% (D), 25% (E), 50% (F), and 100% 
(G); ‘L’: 100 bp DNA ladder; ‘EC’: Extraction control; ‘NTC’: Non-template control; ‘1-4’: 
aborting cows from whom the plasma samples were obtained for spiking with fetal serum/cellular 
DNA followed by DNA extraction and PCR. ‘B’ and ‘C’: Bull and heifer PCR controls with 
presence and absence of 210 bp Y-specific gene sequence, respectively. 
3.5a (Maternal plasma spiked with male fetal serum) 
3.5b (Maternal plasma spiked with male fetal cellular DNA) 
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3.4.2. Minimum range of spiked fetal DNA concentration needed for successful re-
extraction (Trial 5a) 
The PCR results for Y-specific (Figures 3.6a and 3.6b) and bAML (Figures 3.6c and 3.6d) genes 
in plasma samples of non-pregnant heifers and pregnant cows spiked with different concentrations 
of male fetal DNA are shown in Tables 3.5 and 3.6, respectively. The lower range of cffDNA re-
extracted and detectable by Y-specific and bAML gene PCR was 16-69 pg/300 µl (approximately 
53-230 pg/ml) and 0.63-1.3 ng/300 µl of maternal plasma (approximately 2.1-4.3 ng/ml), 
respectively. We did not observe Y-specific 210 bp and male fetus-specific bAML (341 bp) 
amplicons in the non-spiked neat plasma samples from non-pregnant heifers and pregnant cows. 
No bands in the negative controls confirmed a contamination-free DNA extraction and PCR 




























Figure 3.6: Y-specific and bAML PCR results when known amount of cellular DNA from aborted 
male fetii was spiked in plasma of unrelated heifers and pregnant cows (120-150 days pregnant; 
carrying male fetii). From this initial dilution step, subsequent serial dilutions were made in a 
1:20 manner and DNA re-extraction was performed from all the diluted plasma samples followed 
by PCR. ‘EC’: Extraction control; ‘NT’: Non-template control; ‘L’: 100 bp DNA ladder; ‘H1-
H5’and ‘C1-C5’: neat plasma from heifers and pregnant cows, respectively used for DNA 
extraction and PCR; ‘A’: DNA re-extraction and PCR from plasma samples of each heifer/cow 
spiked with known amount of male fetal cellular DNA; ‘B-H’: subsequent serially diluted plasma 
samples of the respective heifers/cows with an expected known amount of male fetal cellular DNA 
(A: No serial dilution; B: 2×10-1, C: 2×10-2, D: 2×10-3, E: 2×10-4, F: 2×10-5, G: 2×10-6, H: 2×10-
7); ‘b’ and ‘c’: Bull and heifer PCR controls, respectively. 
 
3.6a (Y-specific; Heifer plasma samples spiked 
with fetal cellular DNA) 
3.6b (Y-specific; Pregnant cows’ plasma samples 
spiked with fetal cellular DNA) 
3.6c (bAML; Heifer plasma samples spiked 
with fetal cellular DNA) 
3.6d (bAML; Pregnant cows’ plasma samples 




Table 3.5: PCR results of plasma samples spiked with serial dilutions of fetal DNA from the aborted male fetii and tested for Y-specific 
gene. Non-pregnant heifers (H1-H5) and pregnant cows (C1-C5: 120-150 days gestation, carrying male fetus). 
Dilution rate 
Male fetus specific amplicon in Y-specific primers PCR 
H1 C1 H2 C2 H3 C3 H4 C4 H5 C5 
Undiluted + + + + + + + + + + 
2x10-1 + + + + + + + + + + 
2x10-2 + + + + + + + + + + 
2x10-3 + + + + + + + + + + 
2x10-4 + - + + - - - - - + 
2x10-5 - - - - - - - - - - 
2x10-6 - - - - - - - - - - 
2x10-7 - - - - - - - + - - 
Non-spiked neat heifer/cow 
samples 
- - - - - - - - - - 
‘+’ and ‘–’ indicate the presence and absence, respectively, of gene amplicon (210 bp) in PCR. 
Table 3.6: PCR results of plasma samples spiked with serial dilutions of fetal DNA from the aborted male fetii and tested for bAML 
gene. Non-pregnant heifers (H1-H5) and pregnant cows (C1-C5: 120-150 days gestation, carrying male fetus). 
Dilution rate 
Male fetus specific amplicon in bAML PCR 
H1 C1 H2 C2 H3 C3 H4 C4 H5 C5 
Undiluted + + + + + + + + + + 
2x10-1 + + + + + + + + + + 
2x10-2 + + + + + + + + + + 
2x10-3 + - + - - - - - - - 
2x10-4 - - - - - - - - - - 
2x10-5 - - - - - - - - - - 
2x10-6 - - - - - - - - - - 
2x10-7 - - - - - - - - - - 
Non-spiked neat heifer/cow 
samples 
- - - - - - - - - - 








3.4.3. Lowest concentration of spiked male fetal DNA for a successful PCR (Trial 5b) 
The Y-specific PCR (Figures 3.7a and 3.7b) results showed that male fetus-specific amplicons 
could be detected in maternal plasma at spiking concentrations > 9.4 pg/300 µl (>31.25 pg/ml, 
Table 3.7). When this concentration was converted to the DNA copy number, 10 copies of the 
whole fetal genome/ml of maternal plasma are needed for a successful PCR. Further, the PCR 
designed to target the bAML sequence (Figures 3.7c and 3.7d) appeared to be less sensitive as 
even at 600 pg/300 µl (2 ng/ml) concentration of male fetal DNA in maternal plasma, 341 bp 
bAML sequence (specific to the male fetus) was observed in four out of five non-pregnant 
heifer/pregnant cows (Table 3.8). When this concentration was converted to the DNA copy 
number, the figure came out to be 648 copies of the whole fetal genome/ml of maternal plasma. 
We did not observe male fetus-specific amplicons for Y-specific and bAML genes in the non-
template control and the neat plasma samples of any of the pregnant cows carrying a male fetus. 
























Figure 3.7: A representative gel image of Y-specific and bAML PCR results when known amount 
of cellular DNA (2 ng) from aborted male fetii was spiked in 1000 µl plasma of unrelated heifers 
and pregnant cows (120-150 days pregnant; carrying male fetii). From this initial dilution, further 
dilutions were made in a way to have half the amount of fetal DNA than the previous one. ‘EC’: 
Extraction control; ‘NT’: Non-template control; ‘L’: 100 bp DNA ladder; ‘H1-H3’ and ‘C1-C3’: 
neat plasma from heifers and pregnant cows, respectively used for DNA extraction and PCR; ‘A’: 
DNA re-extraction and PCR from plasma samples of each heifer/cow spiked with known amount 
of male fetal cellular DNA; ‘B-J’: subsequently diluted plasma samples of the respective 
heifers/cows with an expected known amount of male fetal cellular DNA/ml of maternal plasma 
(A: 2 ng, B: 1 ng, C: 500 pg, D: 250 pg, E: 125 pg, F: 62.5 pg, G: 31.25 pg, H: 15.62 pg, I: 7.81 
pg, J: 3.9 pg) ; ‘b’ and ‘c’: Bull and heifer PCR controls, respectively. 
3.7a (Y-specific; Heifer plasma samples spiked 
with fetal cellular DNA) 
3.7b (Y-specific; Pregnant cows’ plasma 
samples spiked with fetal cellular DNA) 
3.7c (bAML; Heifer plasma samples spiked 
with fetal cellular DNA) 
3.7d (bAML; Pregnant cows’ plasma samples 
spiked with fetal cellular DNA) 
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Table 3.7: Results of Y-specific PCR conducted on plasma samples spiked with male cffDNA. 
Plasma of unrelated non-pregnant heifers (H1-H5) and pregnant cows (C1-C5: 120-150 days 
gestation, male fetus) were used. 
Amount of male fetal DNA expected in the 
spiked plasma of heifers/cows 
Y-specific PCR  
Fetal DNA/ml of 
plasma 
Fetal DNA/300 µl of 
plasma (used for re-
extraction) 
H1 H2 H3 H4 H5 C1 C2 C3 C4 C5 
2 ng 600 pg + + + + + + + + + + 
1 ng 300 pg + + + + + + + + + + 
500 pg 150 pg + + + + + + + + + + 
250 pg 75 pg + + + + + + + + + + 
125 pg 37.5 pg + + + + + + + + + + 
62.5 pg 18.7 pg + + + + + + + + + + 
31.25 pg 9.4 pg + + + + + + + + + + 
15.62 pg 4.7 pg - + - + - + + + - - 
7.81 pg 2.3 pg - + - - - + - - - - 
3.9 pg 1.2 pg - - - - - - - - - - 
Non-spiked neat heifer/cow plasma (300 
µl) used for DNA extraction 
- - - - - - - - - - 
‘+’ and ‘–’ indicate the presence and absence, respectively, of gene amplicon (210 bp) in PCR. 
Table 3.8: Results of bAML PCR conducted on plasma samples spiked with male cffDNA. Plasma 
of unrelated non-pregnant heifers (H1-H5) and pregnant cows (C1-C5: 120-150 days gestation, 
male fetus) were used. 
Amount of male fetal DNA expected in 
the spiked plasma of heifers/cows 
bAML PCR  
Fetal DNA/ml of 
plasma 
Fetal DNA/300 µl of 
plasma (used for re-
extraction) 
H1 H2 H3 H4 H5 C1 C2 C3 C4 C5 
2 ng 600 pg + + + + - + + - + + 
1 ng 300 pg - - - - - + - - + - 
500 pg 150 pg - - - - - - + - - - 
250 pg 75 pg - - - - - - + - - - 
125 pg 37.5 pg - - - - - - + + - - 
62.5 pg 18.7 pg - - - - - - - - - - 
31.25 pg 9.4 pg - - - - - - - - - - 
15.62 pg 4.7 pg - - - - - - - - - - 
7.81 pg 2.3 pg - - - - - - - - - - 
3.9 pg 1.2 pg - - - - - - - - - - 
Non-spiked neat heifer/cow plasma (300 
µl) used for DNA extraction 
- - - - - - - - - - 
‘+’ and ‘–’ indicate the presence and absence, respectively, of gene amplicon (341 bp) in PCR. 
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3.4.4. Effect of gestation stage at sampling on prenatal fetal sexing using PCR (Trial 6) 
Considering our observation that Y-specific PCR would detect lower concentrations of cffDNA 
than bAML PCR, we decided to use the former to compare two groups of cows at different stages 
of gestation for prenatal fetal sexing. The result of Y-specific PCR on spiked (Figure 3.8a) plasma 
samples (positive control) and neat (Figure 3.8b) plasma samples from cows 60-150 days pregnant 
(n=9) versus cows 151-240 d pregnant (n=10) are described in Table 3.9. The proportion of cows 
with a PCR positive sample were lower in the 60-150 d gestation group (CI: 7.5-70.1) than the 
151-240 d group (CI: 55.5-99.75), 3/9 versus 9/10 (P<0.05). All spiked samples of pregnant cows 
and non-pregnant heifers showed the expected 210 bp Y-specific amplicons, while the neat 
samples from non-pregnant heifers and non-template control did not yield any PCR product. 



















                                   
 
  
                             
 
Figure 3.8: Y-specific PCR results when spiked (with 35 pg male fetal DNA/ml) and neat plasma 
samples from non-pregnant heifers and pregnant cows carrying male fetii grouped in two 
gestational stages (60-150 days pregnant versus 151-240 days pregnant) were subjected to DNA 
extraction. ‘EC’: Extraction control; ‘NTC’: Non-template control; ‘L’: 100 bp DNA ladder; ‘H1-
H5’: Heifer DNA samples; ‘c1-c9’: DNA samples from 60-150 days pregnant cows; ‘C1-C10’: 
DNA samples from 151-240 days pregnant cows; ‘b’ and ‘c’: Bull and heifer PCR controls, 
respectively. 
3.8a (Heifers and pregnant cows’ plasma samples spiked with 
lower limits of male fetal DNA) 
3.8b (Neat plasma samples of heifers and pregnant cows) 
85 
 
Table 3.9: Results of Y-specific PCR. Extracted DNA from neat and spiked (with 35 pg/ml male 
cffDNA) plasma samples from non-pregnant heifers (n=5) and pregnant cows (n=19) were used. 
Non-pregnant heifers 60-150 days pregnant cows 151-240 days pregnant cows 














1 + - 1 + - 1 + + 
2 + - 2 + + 2 + + 
3 + - 3 + - 3 + + 
4 + - 4 + - 4 + + 
5 + - 5 + + 5 + + 
6 + - 6 + + 
7 + - 7 + + 
8 + + 8 + + 
9 + - 9 + - 
10 + + 









3.4.5. Comparison of DNA extraction methods for Y-specific PCR (Trial 7) 
The results of Y-specific PCR conducted on DNA extracted from neat and spiked plasma samples 
using three commercial kits are shown in Table 3.10. The Y-chromosome-specific sequence was 
successfully amplified in all the DNA extracts obtained from the spiked plasma samples using all 
three kits compared (Figures 3.9a, 3.9b, and 3.9c). However, the Y-specific sequences were 
amplified in 3/5, 1/5, and 0/5 DNA extracts obtained from neat plasma samples using DNeasy 
Blood and Tissue Kit (Figure 3.9a), Qiagen DSP Virus Kit (Figure 3.9b), and NucleoMag cfDNA 
Isolation Kit (Figure 3.9c), respectively (Table 3.10). A clean non-template control and appropriate 
amplification in positive controls indicated successful PCR. 
Table 3.10: Results of Y-specific PCR comparing different extraction methods. Neat and spiked 
(with 35 pg/ml male cffDNA) plasma samples from pregnant cows (181-240 days gestation, 
carrying male fetus) were extracted using three commercial kits.  
Kits used for DNA extraction 
Spiking 
status 
Y-specific PCR output (n=5 replicates each) 
1 2 3 4 5 
DNeasy Blood & Tissue Kit 
Neat  + - - + + 
Spiked + + + + + 
DSP Virus Kit 
Neat + - - - - 
Spiked + + + + + 
NucleoMag cfDNA Isolation Kit 
Neat  - - - - - 
Spiked + + + + + 












                   
 
                   
 
                   
 
Figure 3.9: Y-specific PCR results following DNA extraction using neat and spiked (with 35 pg 
male fetal DNA/ml) plasma samples from pregnant cows carrying male fetii (181-240 days 
pregnant). DNeasy Blood & Tissue Kit, Qiagen DSP Virus Kit, and NucleoMag cfDNA Isolation 
Kit were used on same set of plasma samples. ‘NTC’: Non-template control; ‘L’: 100 bp DNA 
ladder; ‘EC’: Extraction control; ‘1-5’: DNA samples obtained from neat and spiked plasma 
samples of pregnant cows; ‘b’ and ‘c’: Bull and heifer PCR controls, respectively. 
3.9a (DNeasy Blood & Tissue Kit) 
3.9b (Qiagen DSP Virus Kit) 




To the best of our knowledge, the present study is novel in identifying the lower limits of cffDNA 
in the plasma of pregnant cattle for a PCR-based prenatal fetal sexing. We also determined that 
the a) Y-specific PCR would amplify spiked cffDNA at lower concentrations than the bAML PCR, 
and b) the sensitivity of prenatal fetal sex determination using PCR was superior in cows sampled 
in the second half of gestation than during the first half of gestation. Lastly, the lowest 
concentrations of spiked cffDNA could be successfully re-extracted with all extraction methods 
and amplified using Y-specific PCR; however, the results of PCR were variable when neat plasma 
was used.  
Findings of our initial spiking experiment showed that cffDNA could be successfully extracted 
and amplified with the Y-specific gene PCR when the fetal serum fraction in the maternal plasma 
was as low as 0.5% (v/v). Results were similar when extracted fetal cellular DNA was added at 
the same (0.5% v/v) dilution rates. A couple of previous studies have indicated that PCR could 
successfully amplify Y-specific PCR products if the proportion of male to female DNA was 1% 
but not at 0.1% proportion (Cruz et al., 2011; Da Cruz et al., 2012). Interestingly, we could not 
amplify PCR products in the non-spiked samples of cows that aborted a male fetus. At least in 
women, the mean half-life of fetal DNA in maternal circulation was reported to be 16.3 minutes, 
indicating a rapid clearance of cffDNA following delivery (Dennis Lo et al., 1999). Since we 
collected the plasma samples from aborting cows within 24 h of abortion, it is possible that the 
cffDNA either was below the detection limits or was cleared out from the maternal peripheral 
circulation.  
Our subsequent spiking trials provided more insights into the lowest amount of cffDNA that could 
be successfully re-extracted and used for PCR (both bAML and Y-specific). We observed that Y-
specific PCR successfully amplified PCR products if the fetal DNA concentration was between 
53-230 pg/ml of maternal plasma. When the same primers were used in a previous report, the 
lowest concentration of DNA needed for a successful Y-specific PCR was indicated to be 0.4 pg 
(Cruz et al., 2011; Da Cruz et al., 2012). In the current study, with the same elution volume as for 
Y-specific PCR, the successful amplification of male fetus-specific bAML gene sequences was 
observed when male fetal DNA was present in the range of approximately 2.1-4.3 ng/ml. Selected 
Y-specific primers might likely have better efficiency than bAML primers. In a follow-up spiking 
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experiment, we determined the threshold limits for consistent amplification of male fetal Y-
specific and bAML gene sequences with PCR as >31.25 pg/ml and 2ng/ml of maternal plasma, 
respectively, when DNA elution volume was decreased. Considering the size of the whole bovine 
fetal genome to be 2,857,605,192 base pairs (Zimin et al., 2009), a minimum of at least ten copies 
of the entire fetal genome must be present in one milliliter of maternal plasma for successful 
extraction of fetal DNA for Y-specific 210 bp primer PCR used in this study. Our observation 
corresponds with an older study in humans that has suggested approximately ten copies of fetal 
DNA circulating per milliliter of maternal plasma for prenatal fetal sex determination (Dennis Lo 
et al., 1989). However, about 648 copies of bovine fetal DNA must be present per milliliter of 
maternal plasma for successful extraction and amplification using bAML PCR. 
Our subsequent trial indicated that the sensitivity of the Y-specific PCR for fetal sexing was higher 
for cows between 151-240 days pregnant (CI: 55.5-99.75) compared to 60-150 days pregnant (CI: 
7.5-70.1). Although a limited number of animals were included in our trial, this finding suggested 
that cffDNA fraction may be higher during the second-half of gestation, similar to the observations 
made in pregnant women (Dar et al., 2016; Dennis Lo, Tein, et al., 1998). Collectively, these 
findings support the notion that the concentration of fetal DNA might gradually rise with 
advancement in gestation but needs to be tested in a larger number of animals. A similar trend of 
correctly predicting bovine fetal sex using PCR with advancement in gestation was also reported 
in an earlier study (Da Cruz et al., 2012), however, the authors observed that fetal sex could be 
correctly predicted with 99.9% accuracy 55 days post-conception. In our case, the sensitivity of 
correctly predicting male fetal sex in cows lesser than five months pregnant was just 33%, which 
is in concordance with an earlier study where authors had reported a 25% sensitivity of 
successfully amplifying fetal Y-chromosome specific sequences in pregnant cows around their 
mid-gestation (i.e., 150 days pregnant) (Turin et al., 2007). The sensitivity of correctly identifying 
fetal sex using Y-specific PCR in cows greater than 150 days pregnant was 90% in our case which 
is in agreement with an earlier finding by Davoudi and co-workers who have reported that the ease 
of identifying bovine fetal DNA using PCR rises as the pregnancy advances (Davoudi et al., 2011). 
However, our observations need to be further tested on a larger dataset to obtain a statistically 
meaningful comparison with regards to the sensitivity, specificity, and accuracy of the PCR assay 
for fetal sexing in pregnant cows. In another study, the accuracy of PCR-based bovine fetal sexing 
was found to be 60% and 92% for cows 30-60 and 121-240 days pregnant, respectively (Xi, 2006). 
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A study conducted on pregnant mares also reported a gradual increase in the accuracy of PCR-
based fetal sexing from the first to the third trimester of pregnancy (48.75%, 68.75, and 75%, 
respectively) (Tonekaboni et al., 2020). In the same trial, the spiked cffDNA (@ 35 pg/ml of 
maternal plasma) was successfully re-extracted and detected using Y-specific PCR from both 
gestational groups of cows. It is possible that in the samples which did not show Y-specific 
amplicons, the inherent cffDNA fraction was below the detectable limits or may be present in 
fragmented form in contrast to the spiked fetal DNA.  
Our last trial further confirmed the variability of results with Y-specific PCR when we used 
different DNA extraction methods for samples obtained from cows 181-240 days in gestation. The 
spiked fetal DNA could be successfully re-extracted from all the samples when the same set of 
spiked plasma was subjected to extraction using all three kits. However, when neat plasma samples 
from the same pregnant cows were used for DNA extraction and Y-specific PCR, successful 
amplification was observed in 3/5, 1/5, and 0/5 plasma extracts obtained using DNeasy Blood & 
Tissue Kit, QIAamp DSP Virus Kit, and NucleoMag cfDNA Isolation Kit, respectively. Several 
authors reported similar findings that demonstrated different cfDNA extraction methods to yield 
different results for prenatal fetal sexing when DNA extraction was performed on the same set of 
plasma samples obtained from pregnant cows (Davoudi et al., 2011; Ristanic et al., 2018).  In 
addition, we noticed a lack of consistency amongst the DNA extraction method in the present 
study. The DNA extraction methods used in the study yielded different results on different days, 
although the performance of the DNeasy Blood & Tissue Kit was comparatively consistent than 
its counterparts. The fundamental differences in extraction methods and highly fragmented nature 
of cffDNA (K. C. A. Chan et al., 2004; Li et al., 2004) along with the transient release of fetal 
DNA in cows (Turin et al., 2007) might somewhat explain the lack of consistency of results 
between the kits (K. C. A. Chan et al., 2004; Dar et al., 2016; Li et al., 2004). However, further 
studies are warranted on a larger number of animals to identify extraction methods with higher 
accuracy and repeatability. 
In summary, Y-specific sequence PCR assay had a lower limit of detection than the bAML PCR 
assay for prenatal fetal sexing. Furthermore, the sensitivity of fetal sexing by Y-specific PCR was 




Fetal serum and cfDNA from aborted male fetii spiked in plasma of their respective dams could 
be successfully re-extracted for Y-specific PCR even at the lowest proportion (0.5%, v/v). Under 
our laboratory conditions, the minimum threshold of cffDNA needed for successful extraction and 
amplification were ≥31.25 pg/ml and ≥2 ng/ml of maternal plasma for Y-specific PCR and bAML 
PCR, respectively. In other terms, at least 10 and 648 copies of the whole fetal genome must be 
present per milliliter of maternal plasma for successful extraction, followed by Y-specific and 
bAML PCR, respectively. Moreover, the chances of successfully amplifying male fetal gene 
sequences increased in advanced stages of pregnancy in cattle; however, the cffDNA might be 




4. GENERAL DISCUSSION AND FUTURE DIRECTIONS 
4.1. General discussion 
Since the discovery of cffDNA in the peripheral blood circulation of pregnant women (Dennis Lo 
et al., 1997), various assays have been developed to use fetal DNA for prenatal fetal sex 
determination (Dennis Lo, Tein, et al., 1998; Sekizawa, Kondo, et al., 2001) and genetic screening 
of the heritable diseases (Bianchi, 2012; Ferrari et al., 2015; Mennuti et al., 2015; Skrzypek & Hui, 
2017). Although the synepitheliochorial placenta of cattle is least invasive due to lack of direct 
contact between maternal bloodstream and fetal trophoblast (P. Wooding & Burton, 2008), the 
phenomenon of transplacental passage of fetal DNA has been demonstrated in cattle (Turin et al., 
2007). Considering the low quantities of fetal DNA in the blood circulation of pregnant cows, 
sample handling and DNA extraction methodologies play a critical role in determining the success 
of PCR-based prenatal sex determination assay (Davoudi et al., 2012; Ristanic et al., 2018). So, 
the first experiment of the present study was aimed to identify the ideal sample type and DNA 
extraction methodology for PCR-based prenatal fetal sex determination in pregnant cows. The 
second experiment was focused on determining the lower limits of cffDNA in bovine plasma 
samples needed for successful PCR detection. 
Our first trial failed to amplify fetal gene sequences in the PCR with frozen-thawed plasma samples 
from pregnant cows. In contrast, fresh plasma samples from pregnant cows resulted in the 
successful amplification of fetal gene sequences. Previously studies in pregnant cattle have used 
fresh plasma and blood for DNA extraction and prenatal fetal sex determination (Da Cruz et al., 
2012; Ristanic et al., 2018), whereas others have successfully used frozen-thawed plasma for the 
same purpose (Davoudi et al., 2011; G. Wang et al., 2010). The contrasting results between frozen 
and fresh plasma samples in the present study could be attributed to the fragmentation of cffDNA 
in samples subjected to the freeze-thaw cycles (K. A. Chan et al., 2005; El Messaoudi et al., 2013) 
owing to the existence of cfDNA in a highly degradable form in the biological samples (Sanchez 
et al., 2018; Zandvakili & Lazaridis, 2019). Further, it is possible that a very low fetal fraction of 
cfDNA resulted in the amplification of the maternal cfDNA similar to previous reports in samples 
from pregnant women (Dennis Lo, Tein, et al., 1998). The exceedingly high proportion of maternal 
DNA (93.8-96.6%) compared to fetal DNA (3.4-6.2%) in pregnant women (Dennis Lo, Tein, et 
al., 1998) has been proposed to overshadow the smaller fetal DNA molecules (Wright & Burton, 
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2009), making the extraction of fetal DNA even more challenging. While 467 bp bAML sequence 
(from X-chromosome) served as the internal control for every DNA extraction, the lack of 
amplification of maternal cfDNA from some samples processed with the phenol-chloroform 
method was perplexing. The persistence of PCR inhibitors (Lemarchand et al., 2005; Nolan et al., 
2006) or samples contamination due to multiple tube transfer steps in the phenol-chloroform 
method could be the likely reasons for the lack of amplification of maternal cfDNA (Köchl et al., 
2005). In contrast, DNeasy Blood and Tissue and MagMAX cfDNA isolation kits amplified the 
internal control bAML sequence at all instances, possibly due to additional washing steps for these 
kits. Although the lower number of samples in the present study did not allow a statistically 
meaningful comparison regarding the relative efficiency of seven different DNA extraction 
methodologies, our findings supported earlier evidence of wide variability in the yield of cffDNA 
amongst the extraction protocols (Davoudi et al., 2011; Ristanic et al., 2018). 
The results of our second experiment indicated that spiked cffDNA could be re-extracted for PCR 
if the fetal fractions in maternal plasma are around 0.5%, which is lower than the previous report 
of 1% fetal fraction needed for a successful PCR for fetal sexing in pregnant cattle (Cruz et al., 
2011; Da Cruz et al., 2012). Further, we observed that the simultaneously processed neat samples 
from the same pregnant cows did not yield Y-specific amplicons, suggesting either absence or very 
low quantities of cffDNA in the maternal plasma. Some studies in humans have shown that 
cffDNA is highly fragmented (Dennis Lo et al., 2010; Sun et al., 2019) that could be one of the 
most important reasons for its extremely challenging extraction from the maternal plasma 
(Keshavarz et al., 2015). Studies need to be carried out comparing manually fragmented fetal DNA 
with intact fetal DNA and cffDNA in the maternal plasma to confirm or refute this notion in cattle. 
Our trials also provided the minimum threshold of cffDNA for the Y-specific PCR and bAML 
PCR in pregnant cattle to be >31.25 pg/ml and 2 ng/ml of maternal plasma, respectively. Based on 
the size of the whole bovine genome (Zimin et al., 2009), these values of cffDNA would reflect 
into approximately 10 and 648 copies of whole fetal genome per ml of maternal plasma for 
successful extraction of cffDNA for Y-specific sequence and bAML PCR.  Our trials also indicated 
that the likely differences of PCR efficiencies between bAML and Y-specific primers should be 
considered for future experiments. 
Subsequently, we used the minimum threshold levels of cffDNA for further testing of Y-specific 
sequence-based PCR to compare the effect of stage of gestation on the sensitivity of PCR in 
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detecting fetal sex. Interestingly, despite the low number of animals recruited for the study, we 
observed significant differences in PCR results for cows between the first and second half of 
gestation. These difference in results of PCR-based fetal sexing with the advancement of 
pregnancy needs to be further studied as our result corroborates with the findings of some studies 
(Da Cruz et al., 2012; Davoudi et al., 2011; Turin et al., 2007) but not others (Lemos et al., 2011; 
Ristanic et al., 2018). Considering the higher relative efficacy of PCR-based prenatal fetal sex 
determination in the later stage of gestation as observed in the present study, the use of this 
technique might not align with fall pregnancy checks in beef herds of western Canada because 
most of the cows are more than 90 but less than 150 days pregnant at that time.  
In summary, our preliminary studies on the development of PCR-based fetal sexing method in 
pregnant cattle have provided crucial information about the minimum threshold of cffDNA 
required for successful PCR and highlighted the limited success with the current approaches for 
the field adaptability. 
4.2. Future directions 
Determine extraction efficiency of fragmented cffDNA 
To date, few reports in humans have shown that cffDNA is highly fragmented (Dennis Lo et al., 
2010; Sun et al., 2019), which could be one of the most important reasons for its poor extractability 
from the maternal plasma (Keshavarz et al., 2015). Future experiments may be designed using 
manually fragmented cffDNA from blood cells/tissues of aborted male fetii to determine the 
extraction efficiency from the plasma samples. More specifically, after manual fragmentation, fetal 
DNA fragments may be selectively picked based upon their size to test re-extraction efficiency.  
Determine fetal DNA distribution in different trimesters of pregnancy 
Besides, a few reports suggest that the concentration of fetal DNA in maternal plasma gradually 
increases with advancement in gestation both in humans (E. Wang et al., 2013) and cattle (Da Cruz 
et al., 2012; Davoudi et al., 2011). An experiment may be designed to extract cffDNA from the 
plasma of pregnant cows grouped in different stages of gestation (first-trimester group; second-
trimester group; third-trimester group). The extracted DNA could be subjected to gel fractionation 
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and PCR to determine the prevalence size of fetal DNA fragments in maternal plasma and test the 
accuracy of PCR-based fetal sex determination. 
Magnetic beads-based approach to obtain fetal DNA from plasma/serum of pregnant cows 
Since it has been reported that significantly higher yields of maternal DNA in the serum/plasma 
samples prevent the retention of minutely present fetal DNA (Suzuki et al., 2008), alternative 
approaches to specifically target male fetal DNA sequences in maternal serum may be used. One 
such method is based upon the use of capture probes (oligonucleotides) modified and specifically 
designed to hybridize to a desired DNA sequence which may ultimately be eluted through 
magnetic beads-based technology. This technology has been earlier used to extract scarcely 
present Toxoplasma gondii DNA in meat samples (Opsteegh et al., 2010) and extraction of urine 
cfDNA (Oreskovic et al., 2019) for diagnostic purposes. We hypothesize that the same 
oligonucleotide-based magnetic capture technique may be used for obtaining the male fetus-
specific DNA sequences for sex-determination purposes with slight modifications. Yet, this 
technique is relatively new and is still evolving, so not much data is available to support its 
feasibility. The high cost/sample might be one major limiting factor hindering the adoption of this 
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